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Antimicrobial agents are used to treat and prevent bacterial infections. In cattle, 
antimicrobials are most often used to control, treat, or prevent respiratory disease and liver 
abscesses in feedlot cattle and mastitis in dairy cows. Liver abscesses occur in feedlot cattle 
because of feeding an energy dense, high grain diet. The primary causative agent is Fusobacterium 
necrophorum, a ruminal bacterium that enters portal circulation to reach the liver and cause 
abscesses. Currently, in-feed tylosin is widely used to reduce the incidence of liver abscesses. 
Mastitis, an economically important disease of dairy cows, is caused by a number of 
bacterial pathogens, mainly Staphylococcus aureus, Streptococcus agalactiae, S. dysgalactiae, S. 
uberis, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli. Beta-lactams, 
macrolides (erythromycin), and lincosamides are the common antimicrobials used for mastitis 
prevention and treatment. Additionally, foodborne illnesses are a major public health concern and 
food animals are major carriers of many foodborne pathogens. Three major foodborne bacterial 
pathogens that reside in the gut and are shed in the feces of cattle are Shiga toxin-producing E. 
coli, Salmonella enterica, Campylobacter jejuni, and C. coli. The most common antimicrobials 
used to treat Salmonella and Campylobacter infections in humans are fluoroquinolones, 
macrolides, cephalosporins, and diaminopyrimidine plus sulfa drug combinations. 
Antimicrobial resistance (AMR) to antimicrobials, particularly to medically important 
antimicrobials, such as cephalosporins, fluoroquinolones, and macrolides, are a major public 
health concern. Antimicrobial resistance occurs in pathogens as well as in commensals. Because 
of a clear association between antimicrobial use and emergence of AMR, there are efforts to restrict 
and minimize the use of antimicrobials, and at the same time, if possible, replace with antimicrobial 
alternatives. In my studies, I have focused on the following three antimicrobial alternatives: 
  
bacteriophages, clustered regularly interspaced short palindromic repeats (CRISPR) with 
CRISPR-associated proteins (Cas), and sorghum grain phenolic extract. Therefore, the main 
objectives were to evaluate the potential of bacteriophages, CRISPR-Cas9, and phenolic extracts 
of sorghum grains to inhibit major pathogens of liver abscesses, mastitis, and foodborne illnesses 
associated with cattle. 
Bacteriophages are viruses that infect bacteria and cause them to lyse (lytic bacteriophages) 
and are known for their host specificity. Therefore, we hypothesized that bacteriophages could be 
an effective tool to selectively target and eliminate or reduce the concentration of F. necrophorum 
in the rumen, thereby minimizing the chance for it to cross the ruminal epithelium to reach the 
liver to cause abscesses.  Studies were conducted to isolate and characterize bacteriophages lytic 
to F. necrophorum. Pooled bovine ruminal fluids from slaughtered cattle at abattoirs and untreated 
city sewage samples were collected on five separate dates. A total of 68 F. necrophorum subsp. 
necrophorum strains of liver abscess origin were used to isolate bacteriophages. Aliquots of pooled 
ruminal fluid or sewage samples were incubated anaerobically overnight with lysine and subsp. 
necrophorum strains. The aliquots were then filtered, bacteria-free filtrates were spotted on lawns 
of the strains, and presence of plaques were considered as positive for phages. Presumptive 
bacteriophage plaques were harvested, and the viruses were purified by serial passaging on the 
susceptible bacterial strains. The bacteriophage isolation frequencies were compared between 
sample types, sampling dates, and F. necrophorum strains. The overall relative frequency of 
isolated bacteriophages lytic to F. necrophorum subsp. necrophorum was 17.1 %. The frequency 
of bacteriophage isolation between collection dates ranged from 0 to 25.4 % for ruminal fluid, and 
from 13.7 to 32.0 % for sewage samples. The frequency of isolation of bacteriophages lytic to F. 
necrophorum subsp. necrophorum from sewage samples was higher (p < 0.0001) than lytic 
  
bacteriophages isolated from bovine ruminal fluid samples. Bacteriophages were isolated more 
frequently with certain F. necrophorum subsp. necrophorum strains than others. The 
characterization of the isolated bacteriophages included determination of host specificity, electron 
microscopic morphology, development of insensitivity, and optimal pH and temperature stability. 
All 25 bacteriophages were lytic to F. necrophorum subsp. necrophorum only and did not lyse 
subsp. funduliforme or any of the other bacterial species tested. Based on morphology determined 
by transmission electron microscopy, twenty bacteriophages belonged to Siphoviridae, 
Myoviridae, or Podoviridae families. Four bacteriophages with icosahedral heads and no tail and 
one with multiple tails could not be unclassified. In broth cultures, 11 bacteriophages inhibited F. 
necrophorum subsp. necrophorum up to 12 hrs, while the other 14 bacteriophages only slightly 
slowed the growth of the bacterium. F. necrophorum subsp. necrophorum became insensitive to 
all 11 lytic bacteriophages after 24 h. At a pH of 2.5, all 11 bacteriophages were inactivated 
immediately, while at a pH of 3.5, six bacteriophages were only partially inactivated upon initial 
exposure and five survived for 1 hr. Between pH 4.5- pH 8.5, no reduction in bacteriophage activity 
was observed. After 24 h of incubation at 30 °C, 40 °C, and 50 °C, lytic activities of the 11 
bacteriophages were unaffected. 
Bacteria use RNA-guided (gRNA) CRISPR-Cas systems to protect against foreign nucleic 
acids, particularly mobile genetic elements, including bacteriophages. Because CRISPR-Cas 
systems can be used to modify genetic material by precisely cutting target nucleotides, we 
hypothesized that the system could be used to inhibit F. necrophorum in the rumen or liver. The 
concept was first tested in E. coli with plasmids that had the F. necrophorum rpsP gene inserted. 
A 1.3- to 3.3-log10 reduction was observed when the rpsP gene was targeted from a plasmid in E. 
coli. The approach was then used to cleave the fomA gene that encodes an outer membrane protein 
  
in F. necrophorum. This resulted in a 1.0- to 3.6-log10 reduction in bacterial cell concentrations. 
However, the Cas9 control reduced bacterial cell concentrations by 2.0-log10 in F. necrophorum. 
This observation was not seen in E. coli. This could be because F. necrophorum has an endogenous 
CRISPR-Cas type I system. More studies should be conducted to determine how this endogenous 
system works and to further determine if CRISPR-Cas systems are possible antimicrobial 
alternatives to tylosin in cattle production. 
Phenolic compounds have antimicrobial properties, and some specialty sorghum grain 
varieties are high in phenolic compounds. Therefore, sorghum grain phenolic extract may have the 
potential to be used as a natural antimicrobial alternative. The antimicrobial effects of sorghum 
phenolic extract on bacterial pathogens that cause bovine mastitis and human foodborne illnesses 
were determined. Bacterial pathogens tested included Shiga toxin-producing Escherichia coli, 
Salmonella Typhimurium, Campylobacter jejuni, C. coli, Pseudomonas aeruginosa, Klebsiella 
pneumoniae, K. oxytoca, Staphylococcus aureus, and Enterococcus faecalis. Antibacterial 
activities of sorghum phenolic extracts at concentrations of 0, 100, 200, 500, 1,000, or 4,000 
µg/mL were determined by agar well diffusion assay. Plates were incubated for 18-24 hours and 
the diameter of each zone of inhibition was measured. The results indicated that sorghum phenolic 
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Chapter 1 - Problems with Antibiotics in Cattle Production 
 Introduction 
Antimicrobials are agents that either kill microbes or inhibit their normal functions such as 
reproduction or growth. Although antimicrobials are most often referred to as agents that impact 
bacteria, antimicrobials also include compounds that kill fungi, viruses, or protozoa. Antibiotics 
are a subset of antimicrobials that are active against various bacteria and are derived from 
microbial sources.  
Antibiotics have been discovered and modified over the last century. One of the first 
antibiotics, Salvarsan, was discovered in 1909 by Ehrlich and was used to treat syphilis through 
oxidation caused by a mixture of arsenic bonded molecules (Taylor, 1942; Lloyd et al., 2005; 
Dougherty and Pucci, 2012). Fleming first published that Penicillium extracts had bacteriostatic 
properties against Gram-positive bacteria in 1929, but he could not isolate the antibacterial 
compound within the mold (Fleming, 2001; Dougherty and Pucci, 2012). In 1940, Ernst Chain 
was able to isolate and identify the compound, and by 1945, penicillin had proved to be a powerful 
antibiotic against Gram-positive bacteria in medicine (Clark, 1985; Dougherty and Pucci, 2012). 
A few years after the isolation of penicillin, in 1943, an antibiotic derived from soil bacteria and 
active against Gram-negative bacteria, streptomycin, was discovered in Waksman’s lab 
(Dougherty and Pucci, 2012). In the years following, the discoveries of penicillin and streptomycin 
antibiotics were rapidly studied through various screening methods, and by the 1970s most major 
antibiotic classes had been discovered (Dougherty and Pucci, 2012).  
As more natural antibiotics were being discovered, synthetic derivatives of these antibiotics 
were starting to be produced by pharmaceutical companies. These derivatives were made to have 
a broader spectrum compared to their natural predecessors. Today, third and fourth-generation 
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antimicrobials are used most often in medicine, and most are very broad-spectrum, working against 
Gram-positive and Gram-negative bacteria.  
Antibiotic and antimicrobial use has rapidly increased since they were first approved in the 
1940s to treat bacterial infections. Antimicrobials have been used in the United States and other 
countries to treat infections in both humans and animals for nearly a century. Food animal 
production has continually increased over time to feed a growing global population, and thus it has 
required an increased need for disease management (Mathew et al., 2007; Amachawadi, 2014). 
Furthermore, maximizing the efficiency of production at every step in the production chain is 
necessary for optimizing food animal production, and the use of antimicrobials provide an increase 
in production due to better animal health, improved feed efficiency, increased growth promotion, 
and reduced foodborne pathogens (Mathew et al., 2007; Amachawadi, 2014). There are four major 
uses of antimicrobials in cattle production (Landers et al., 2012): 
1. Treatment (therapeutic)- treatment of clinically ill animals in the herd. 
2. Control (metaphylactic)- treatment of clinically healthy animals in a herd with 
clinically ill animals. 
3. Prevention (prophylactic)- treatment of clinically healthy animals to prevent 
disease. 
4. Growth promotion- using antimicrobials in feed or water to promote growth or feed 
efficiency of animals. Not using antimicrobials for disease management, but for 
production purposes (FDA, 2012). Currently the use of human medically important 
antimicrobials is not allowed in food animal production for growth promotion in 
the United States (FDA, 2015). 
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For more than 60 years, antimicrobial use in livestock production has been routinely used 
to control and treat diseases, as well as for growth promotion (Amachawadi, 2014). However, 
antimicrobial resistance has become a major public health concern (FDA, 2012, 2015). Therefore, 
research is being conducted on antimicrobial alternatives for use in food animal production.   
 Antimicrobials in Cattle Production: 
Antimicrobials are commonly used in food animal production to control, prevent, and treat 
diseases, and some are used for growth promotion. Most antimicrobials that are medically 
important in human medicine must be prescribed by a veterinarian for use in food animal 
production (FDA, 2015). Some of the commonly used antimicrobials in cattle production are as 
follows (Table 1.1) (7): 
1. Aminoglycoside: Aminoglycosides are bactericidal, water-soluble, and are used to treat 
Gram-negative and Gram-positive bacteria (Farouk et al., 2015). They inhibit bacterial 
growth by binding to the 30S ribosomal subunit, thus inhibiting protein synthesis (Davies 
and Davis, 1968). The beef industry stopped using extra-label aminoglycosides in the early 
2000s. However, some oral aminoglycosides are labeled to treat calf scours, an intestinal 
disease caused by various Escherichia coli strains. (Osaili et al., 2013; Liang et al., 2020).  
2. Amphenicol: Amphenicols are broad-spectrum, fat-soluble, and used to treat bovine 
respiratory disease (2020d).  Many are bacteriostatic but can be bactericidal against some 
bacterial species (Ullah et al., 2017; Assane et al., 2019). They kill bacteria by binding to 
the 50S ribosomal subunit, thus terminally inhibiting protein synthesis (James et al., 1962). 
Florfenicol is largely used to treat calf pneumonia, bovine respiratory disease, and foot rot 
(Salaheen et al., 2019; Yang et al., 2019).  
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3. Macrolide: Most macrolides are bacteriostatic, broad-spectrum, and fat-soluble (Mazzei et 
al., 1993). They inhibit bacteria by inhibiting protein synthesis by binding to the 50S 
ribosomal subunit (Mazzei et al., 1993). Macrolides are a medically important 
antimicrobial, so producers need to be careful not to misuse them (Aidara-Kane et al., 
2018). In food animal production, tylosin is commonly used in the feed to reduce the 
incidence of liver abscesses in feedlot cattle (Nagaraja and Lechtenberg, 2007; Alicia et 
al., 2015; Müller et al., 2018; 2020c). The mode of action of tylosin is to inhibit F. 
necrophorum, which reduces the bacterium's opportunity to enter the portal blood via 
ruminal wall lesions and reach the liver. Liver abscesses are an animal health and welfare 
issue and cause producers substantial economic losses (Nagaraja and Lechtenberg, 2007; 
Tadepalli et al., 2009). 
4. Beta-lactam: Beta-lactams are bactericidal and water-soluble. Their mode of action is to 
inhibit mucopeptide synthesis in the cell wall. Penicillin and Cephalosporin antimicrobials 
are used in food animal production to treat mastitis, foot rot, pneumonia, and bovine 
respiratory disease (2019; 2020f). Beta-lactam antimicrobials are medically important in 
human medicine (FDA, 2015; Aidara-Kane et al., 2018).  
5. Fluoroquinolone: Fluoroquinolones are bactericidal and fat-soluble. They inhibit bacteria 
by impeding with bacterial DNA-gyrase, therefore preventing DNA synthesis. 
Fluoroquinolones can inhibit Gram-negative and Gram-positive bacteria by also inhibiting 
DNA type IV topoisomerase in conjunction with bacterial DNA gyrase (Oliphant and 
Green, 2002). In food production animals, fluoroquinolones are used to treat bovine 
respiratory disease (2020f; 2020a). Furthermore, quinolones are highly used in human 
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medicine, thus are medically important and must be used with care (Oliphant and Green, 
2002).  
6. Sulfonamide: Sulfamides are broad-spectrum and water soluble. They slow the growth of 
bacteria by inhibiting enzymes in the folic acid pathway. In food animal medicine, 
sulfadimethoxine is used to treat bovine respiratory disease, foot rot, shipping fever, and 
calf diphtheria (2020f; Papich, 2021).  
7. Tetracycline: Tetracyclines are bacteriostatic and have broad-spectrum antimicrobial 
activity (Ian and Marilyn, 2001). They inhibit protein syntheses by binding to the 30S 
ribosomal subunit (Ian and Marilyn, 2001). Oxytetracycline is frequently used in the cattle 
industry to treat bovine respiratory disease, foot rot, pink eye, and leptospirosis (2019; 
2020e; 2020f). 
8. Antimycobacterial: Antimycobacterial antimicrobials are used to treat mycobacterium 
infections. They inhibit mycobacterium by inhibiting the synthesis of their cell walls 
(Ballell et al., 2005; Kulkarni et al., 2018). In cattle and humans, they are primarily used 
to treat tuberculosis.   
9. Trimethoprim: Trimethoprim antimicrobials are similar to sulfonamides by also inhibiting 
the folic acid pathway. They do this by not allowing dihydrofolate to reduce to 
tetrahydrofolate via competitive inhibition (Skl̲d, 2011). In the cattle industry, 
trimethoprim antimicrobials are primarily used to treat Listeriosis (Srinivasan et al., 2005). 
10. Ionophores: Ionophore antimicrobials select against Gram-positive bacteria and protozoa 
by transporting ions across the lipid membrane of bacteria, thus disrupting intramolecular 
protein transport (Schelling, 1984; Duffield and Bagg, 2000). Ionophores can be used for 
growth promotion purposes as they are not medically important in human medicine. 
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(Holman et al., 2018; Scott et al., 2019). Monensin and Lasalocid are examples of 
ionophores used to improve feed efficiency for beef and dairy cattle (Schelling, 1984; 
Ensley, 2020). Monensin works by modulating feed intake and altering the rumen 
microbial population by decreasing protozoa and Gram-positive bacteria, thus, increasing 
Gram-negative bacteria in the rumen (Schelling, 1984). These changes benefit cattle health 
by stabilizing the ruminal pH and preventing acidosis (Schelling, 1984; Ensley, 2020).  
 
Table 1.1. Cattle bacterial diseases and the major antimicrobial classes that are used to prevent or 
treat them (Constable et al., 2008; Cockcroft, 2015; Nagaraja, 2018; Thomson, 2019; 2020b). 
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Table 1.1 continued… 
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Table 1.1 continued… 
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 Antimicrobial Resistance in Cattle Production 
Antimicrobial resistance occurs when a pathogen, or another microbe, can survive in the 
presence of an antimicrobial. This typically occurs through genetic modification of the bacteria so 
the bacteria can produce proteins to neutralize the antimicrobials, increase efflux pumps so 
antimicrobials are forced out of the microbe, or change the target of the antimicrobial, such as the 
membrane, so antimicrobials can no longer attach (Gallo, 2013; Gualerzi, 2013). The use of 
antimicrobials can select antimicrobial resistant pathogens and commensal bacteria that can serve 
as vectors that can transfer resistance genes to other pathogenic microbes (Holmes et al., 2016). 
This increase in antimicrobial resistance in human health has led to the need of improved 
antimicrobial stewardship programs by medical professionals (Gozdzielewska et al., 2020).  
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 Modifications of bacteria leading to antimicrobial resistance 
Bacteria can modify themselves to become resistant to various antimicrobials. These 
changes commonly occur through spontaneous mutation, horizontal gene transfer, or 
bacteriophage transfection (Nakata et al., 2010; Snyder, 2013; Volker et al., 2013; Donnelly et al., 
2015). Most modifications occur in proteins, efflux pumps, or the bacterial membrane (Coates, 
2012; Dougherty and Pucci, 2012; Gualerzi, 2013). 
 Proteins  
Proteins leading to antimicrobial resistance can be inherited from bacteria by spontaneous 
mutations or through horizontal gene transfer (Nakata et al., 2010; Volker et al., 2013). These 
bacterial proteins cause resistance by blocking, inactivating, disabling, or digesting the antibiotic 
(Coates, 2012; Dougherty and Pucci, 2012). Most of these proteins are encoded on the 
chromosome or on a plasmid of the bacteria (Claypool et al., 2010; Tanner et al., 2017). 
 Efflux Pumps 
Efflux pumps use energy to expel antimicrobials from the bacterial cell (Dougherty and 
Pucci, 2012). There are five major classes which can all be single or multi-compartment 
transporters that can work on Gram-positive and Gram-negative bacteria (Figure 1.1) (Dougherty 
and Pucci, 2012): 
1. Major Facilitator (MF) superfamily- MF superfamily efflux pumps use proton 
motive force and are the largest characterized family (Fluman and Bibi, 2009). 
They are mostly plasmid-encoded and commonly cause tetracycline and 
chloramphenicol resistance in bacteria (Roca et al., 2009; Somprasong et al., 2021). 
2. ATP-Binding Cassette (ABC) family- ABC family efflux pumps are found in 
bacteria and mammals and are known to have highly specific reactions (Locher, 
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2016). They are typically involved with nutrient uptake and toxin secretion but can 
be involved in antimicrobial resistance in bacteria (Davidson and Chen, 2004). 
3. Resistance-Nodulation-Division (RND) family- RND family efflux pumps 
contribute to the broadest range of antimicrobial resistance in Gram-negative 
bacteria (Fernando and Kumar, 2013). They are overexpressed in many bacteria 
and have also played a role in bacterial virulence (Fernando and Kumar, 2013). 
4. Small Multi-Drug Resistance (SMR) family- SMR family efflux pumps were 
initially discovered in staphylococci isolates (Dougherty and Pucci, 2012). They 
are plasmid-encoded and cause multi-drug resistance in bacteria (Handzlik et al., 
2013; Andersen et al., 2015). 
5. Multi-Drug and Toxic Compound Extrusion (MATE) family- MATE family efflux 
pumps are the most recent efflux pumps to be discovered and described (Dougherty 
and Pucci, 2012). They are chromosome encoded and cause multi-drug resistance 
in bacteria (Fàbrega et al., 2009; Andersen et al., 2015). 
Efflux pumps in Gram-positive bacteria are typically antimicrobial class-specific and 
mediated by the MF superfamily. Some Gram-positive bacteria use the ABC, SMR, or MATE 
family efflux pumps (Handzlik et al., 2013). Gram-negative bacteria have more variety than Gram-
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Figure 1.1. The differences between the five efflux pump families (Laura, 2006). 
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 Membrane Modifications 
Membrane modifications protect the bacteria from antimicrobials by not allowing the 
antimicrobials into the cell (Gualerzi, 2013). Bacterial membranes may alter their pore size or 
shape and may change their surface charges or produce surface proteins (Skl̲d, 2011; Kawasaki, 
2012). These modifications decrease the antimicrobial's likelihood of penetrating the bacterial 
membrane and entering the cell (Gualerzi, 2013). 
 Transfer of antimicrobial resistance 
Bacteria can inherit and transfer antimicrobial resistance in three significant ways: 
horizontal gene transfer, vertical gene transfer, and bacteriophage transfection (Figure 1.2). 
Horizontal gene transfer allows bacteria to directly transfer genetic elements from one bacterium 
to another (46, 52). While vertical gene transfer is the transfer of genetic elements to the next 
generation of bacteria (48). Bacteriophage transfection can occur when lysogenic bacteriophages 
can inherit genetic elements and spread them from one bacterium to other bacteria (48, 49). 
Horizontal gene transfer and lytic bacteriophages spread resistance genes to different 
bacterial species, while vertical gene transfer increases the number of a bacterial species carrying 
the resistance genes. When bacteria are pressured with long-term, low doses of antimicrobials, all 
these mechanisms select for bacteria with antimicrobial resistance (Gualerzi, 2013). This makes it 
possible for single- and multi-drug resistant genes to spread quickly between different bacterial 
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Figure 1.2. The differences between the three methods to transfer antimicrobial resistance. 
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 Antimicrobial resistance in common cattle production antimicrobials 
Antimicrobial resistance has become a major issue around the world in human and animal 
medicine (Aidara-Kane et al., 2018). An increase in resistance to medically important 
antimicrobials, such as macrolides, cephalosporins, and glycopeptides has led to public health 
concerns (Torio and Padilla, 2018; WHO, 2019). Some of the common antimicrobial resistance 
seen in antimicrobials that are used in cattle production are from plasmid-borne, chromosomal, 
efflux pump, or spontaneous mutations, as well as acetylation and methylation of proteins (Skl̲d, 
2011; Krause et al., 2016). For example, aminoglycosides can become resistant to antimicrobials 
by accumulating aminoglycoside-modifying enzymes from horizonal gene transfer, obtaining 
spontaneous mutations or methylations that inhibit aminoglycoside binding, or by acquiring RND 
family efflux pumps (Skl̲d, 2011; Krause et al., 2016). Likewise, macrolide resistance is commonly 
caused by plasmid-borne genes which encode enzymes that methylate the ribosome's nucleotide 
sequence in bacteria (Skl̲d, 2011). Macrolides also have overlapping binding sites, making it easy 
for multi-drug resistance to occur via homologous recombination in bacteria (Descheemaeker et 
al., 2000; Leclercq and Courvalin, 2002). Additionally, bacteria also develop resistance to 
amphenicols, Beta-lactams, quinolones, tetracyclines, sulfamides, antimycobacterials, and 
trimethoprim through horizontal gene transfer, efflux pumps, spontaneous mutations, methylation, 
acetylation, or enzymatic inactivation (Skl̲d, 2011; Ma et al., 2014; Tang et al., 2014; Ou et al., 
2015).  
 Antimicrobial effects on the microbiome 
 Overview of the cattle rumen microbiome 
Cattle rely on the rumen microbiome to digest plants (Huws et al., 2018). The rumen 
microbiome is diverse and complex. It is comprised of bacteria, protozoa, fungi, bacteriophages, 
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and archaea (Wang et al., 2017). Bacteria and bacteriophages are the most prominent microbes in 
the rumen microbiome, compromising an estimate of 1011 cells/ gram and 109 cells/ gram, 
respectively (Wright and Klieve, 2011; Bath et al., 2013; Patel et al., 2014). The microbes work 
symbiotically with each other to produce volatile fatty acids (VFAs) and microbial protein for 
cattle to use (Wright and Klieve, 2011; Bath et al., 2013). The most prominently made VFAs in 
the rumen are acetate, butyrate, and propionate (Bergman, 1990; Morvay et al., 2011). These VFAs 
provide the majority of substrates that offer the cattle energy to support animal maintenance and 
production (Bergman, 1990; Chaves et al., 2008).  
Research on the human microbiome has led to discoveries involving its contribution to 
obesity, malnutrition, diabetes, multiple sclerosis, asthma, eczema, cancer, and other illnesses 
(Iizumi et al., 2017; Leong et al., 2018). From this, the assumption that the rumen microbiome is 
necessary for cattle health and performance can be made.  Therefore, understanding the rumen 
microbiome is crucial for improving cattle performance, as it is likely that optimizing the rumen 
microbiome will enhance cattle health, growth, and efficiency.  
 Factors affecting rumen microbiome establishment in cattle 
 Diet 
The cattle diet is believed to be the most influential factor affecting the rumen microbiome 
(Henderson et al., 2015). When comparing high forage and high starch diets, there are differences 
in the rumen microbiome. These differences include a change in the Firmicutes to Bacteroidetes 
ratio, decreased fibrolytic bacteria, and increased Prevotella (Ehsan et al., 2009; Fernando et al., 
2010; Clemmons et al., 2019). In high starch diets, Bacteroidetes and Proteobacteria species 
increase in concentration (Fernando et al., 2010). The increase in these bacterial species is likely 
due to them being more efficient carbohydrate fermenters and their ability to survive at a lower 
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pH (Flint et al., 2012; Auffret et al., 2017). Lactobacillus species and Streptococcus bovis, both 
lactate-producing bacteria, are also commonly associated with high starch diets (Russell and Hino, 
1985; Nagaraja and Titgemeyer, 2007). These bacteria contribute to cattle having a lower rumen 
pH when fed a high starch diet (Harlow et al., 2017). Furthermore, protozoa concentrations tend 
to increase in the rumen of cattle fed starch-based diets (Neto et al., 2017). 
Methanogenic archaea and fungi are more abundant and diverse in the rumen when cattle 
are fed high forage diets (Mi et al., 2010). The greater diversity of methanogenic archaea likely 
contributes to the increased methane production observed from cattle fed high forage diets (Popova 
et al., 2011; Clemmons et al., 2019). Also contributing to the higher methane production is the 
increased acetate to propionate ratio seen in cattle fed forage-based diets (Hindrichsen et al., 2004; 
Clemmons et al., 2019). Moreover, studies have demonstrated that fungi favor stemmy forages 
over grains (Grenet et al., 1989).  
 Rumen Development 
As cattle age, the rumen develops, and differences are seen in the rumen microbiome. 
Calves tend to have increased levels of Proteobacteria and Firmicutes (Jami et al., 2013). Over 
time the rumen develops which leads to bacterial population changes, one major change is that 
Bacteroidetes increases in concentration while Proteobacteria decreases (Jami et al., 2013). These 
differences are mainly due to calves being milk-fed, whereas adult cattle are fed solid feed 
(Clemmons et al., 2019). Furthermore, protozoa populations are altered as cattle age (Duarte et al., 
2018).   
Weaning age can also affect the rumen microbiome for a short period of time (Meale et al., 
2017; Clemmons et al., 2019). When calves are weaned early, a rapid change is observed in the 
rumen microbiome while when calves are weaned slowly over time, the microbiome can gradually 
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adjust its microbial population (Meale et al., 2017). Once the microbiome is established after 
weaning, it does not seem to alter much as cattle age unless other factors, like diet change, occur 
(Meale et al., 2017).  
 Breed 
There is not much known on the effects of cattle breed on the rumen microbiome. There is 
evidence to suggest that some breeds may contribute to host regulation of the rumen microbiome, 
but it is more likely that individual genetic variation and regulation plays a more significant role 
in rumen microbiome establishment (Hernandez-Sanabria et al., 2013).  
 Antimicrobial effects on the cattle rumen microbiome 
The microbiome is a complex microbial system within many living organisms. This 
microbial system can be easily disrupted by diet, environment, and antimicrobial agents 
(Mazmanian and Round, 2009; Iizumi et al., 2017). Antimicrobial effects on the microbiome are 
an increasing area of study. In humans, antimicrobial use has been positively correlated with 
obesity, type 1 diabetes, asthma, and autoimmune diseases (Iizumi et al., 2017; Leong et al., 2018). 
When younger children are given antimicrobials, the correlation for these diseases increases 
(Iizumi et al., 2017), this association is likely due to the alterations that antimicrobials make on 
the microbiome. Furthermore, antimicrobial use has been shown to alter both the microbiome's 
richness and evenness, leading to decreased overall diversity of bacteria in human digestive tracts 
(Thomas et al., 2017; de Gunzburg et al., 2018).  
Few studies have been performed on the rumen microbiome, but it can be inferred that 
antimicrobials alter the rumen microbiome from the human studies. Likewise, the rumen studies 
that have been completed support this inference (Thomas et al., 2017; Spirito et al., 2018). 
However, it seems that many of these alterations lead to increased animal performance and 
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productivity (Nagaraja and Chengappa, 1998; Spirito et al., 2018). For example, monesin has been 
demonstrated to decrease methane production and improve feed efficiency by altering the rumen 
microbiome so there is a decrease in the acetate-propionate ratio and more Gram-negative bacteria 
(Spirito et al., 2018). Furthermore, monesin has been reported to decrease methanogenic archaea 
and overall Bacteroidales concentrations while increasing Prevotella concentrations (Spirito et al., 
2018). Nevertheless, additional studies should be performed on antimicrobials' effects on the 
rumen microbiome, especially in reference to young calves.  
 Effects of common control and preventative antimicrobials used in cattle production 
on the rumen microbiome 
 Tetracyclines 
Tetracyclines are one of the most widely used antibiotic classes in animal production 
(Gavilán et al., 2015). While no studies were found on the effects of tetracyclines on the rumen 
microbiome, many were found for other animal species. For example, in chickens, tetracycline 
was demonstrated to decrease the prevalence of Bifidobacteriales, Bacteroidales, Clostridiales, 
Desulfovibrionales, Burkholderiales, and Campylobacterales; while increasing the prevalence of 
Enterobacteriales and Lactobacillales (Videnska et al., 2013). Furthermore, in mice, tetracycline 
use has been reported to reduce gut microbial diversity, increase Firmicutes concentrations, and 
decrease Bacteroidetes concentrations (Yin et al., 2015). From these studies, it raises the question 
if tetracycline use alters the rumen microbiome, but studies should be performed to confirm this 
statement.  
 Tylosin 
Tylosin is a macrolide antimicrobial that is used to prevent liver abscesses (Nagaraja and 
Lechtenberg, 2007). Few studies have been performed on the effects of tylosin on the microbiome, 
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but the ones completed have shown no alterations in bacterial diversity (Nagaraja et al., 1999; 
Weinroth et al., 2019). Most of these studies look only at the diversity of the order or phylum of 
bacteria. Therefore, short- and long-term studies should be performed at the genus and species 
level to determine if any differences in the rumen microbiome are seen when using tylosin.  
 Ionophores 
Rumensin is an ionophore that is added to cattle diets to increase productivity and monesin 
is added to cattle diets to increase productivity and decrease methane production (Nagaraja et al.; 
Potter et al.; Dinius et al., 1976; Dawson and Boling, 1983). When added to the diet, monensin 
alters the rumen microbiome, so more propionate is produced (Schelling, 1984). This increase in 
propionate production leads to increased energy for the animal to use (Dinius et al., 1976).  
It has been reported that monesin alters the rumen microbiome by decreasing methanogenic 
archaea, Rikenellaceae, Lachnospiraceae, Butyrivibrio, Pseudobutyrivibrio, and Incertae sedis 
concentrations, while increasing Coriobacteriaceae, Prevotellaceae, Cyanobacteria, and 
Oribacterium concentrations (Schären et al., 2017). Likewise, monesin has been demonstrated to 
decrease the relative abundance of operational taxonomic units of bacteria in the rumen 
microbiome (Kim et al., 2014).  
 Antimicrobial Alternatives 
 A general overview of antimicrobial alternatives 
Antimicrobial alternatives are substances with antimicrobial activity or the same effects as 
antimicrobials but are not antibiotics or their derivatives. They are generally used to replace 
antimicrobials that bacteria have formed resistance against. There has been a growing need to 
discover antimicrobial alternatives due to increasing antimicrobial resistance in disease-causing 
bacterial pathogens and for growth promotion purposes in the cattle industry (Pukrop, 2017). For 
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an antimicrobial alternative to be effective, it needs to have similar, or better, effects as the 
antimicrobial it is replacing (Amachawadi, 2014). There are three major categories of 
antimicrobial alternatives (Ghosh et al., 2019):  
1. Natural: Antimicrobial alternatives that occur naturally in the environment.  
2. Synthetic: Antimicrobial alternatives that are synthetically designed. 
3. Biotechnology-based: Antimicrobial alternatives that use biological processes in their 
design.  
 Potential antimicrobial alternatives for use in the cattle industry 
 Plant Extracts 
Two major categories of plant extracts are phenolic compounds and organic acids. Phenolic 
compounds are derived mostly from plant sources and can interact with proteins, slow degradation 
of ruminal dietary protein, enhance the bioavailability of amino acids, reduce fermentation waste 
products, improve growth efficiency, and are antioxidants (2018). They also have been shown to 
have antimicrobial effects, increase microbial protein, and decrease bloat severity (Jacela et al., 
2013). Antimicrobial activity is believed to be caused by reducing pH, disrupting the bacterial 
membrane's permeability, or altering bacterial efflux pumps (Srivastava et al., 2014). Some 
examples of antimicrobial alternatives containing phenolic compounds are essential oils, sorghum 
extract, and herb extracts (Puupponen‐Pimiä et al., 2001; Sieniawska et al., 2013; Omonijo et al., 
2018; Pempek et al., 2018).  
Essential oils are volatile and aromatic substances extracted from plants (Castillejos et al., 
2007). Research has shown that they improve digestibility, immunity, and promote gut health in 
production animals (Brenes and Roura, 2010; Chitprasert and Sutaphanit, 2014; Omonijo et al., 
2018). Furthermore, essential oils have antimicrobial, antioxidant, and anti-inflammatory activities 
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(Zhang et al., 2006). Their antimicrobial activity is caused by damaging the cell wall of bacteria, 
which leads to cell death (Xu et al., 2008; Yap et al., 2014). Another compound high in phenolics 
is sorghum extract, which is a plant-based compound that has potential as a natural antimicrobial 
alternative (Herald et al., 2012). It has also been shown to have many health and pharmaceutical 
benefits (Dykes and Rooney, 2006). Sorghum grains with increased concentrations of phenolic 
compounds have been associated with higher antioxidant activities, anticarcinogenic effects, and 
antimicrobial activities (Dykes et al., 2005; Guajardo Flores, 2008; Kil et al., 2009). Herbs are 
another common source of phenolic compounds. They are frequently used in diets to increase 
palatability, but they have also been shown to have antimicrobial effects (Cutter, 2000; Terranova 
et al., 2020).   
Organic acids are another common plant extract. They are carboxylic acids that are thought 
to inhibit bacteria by altering rumen pH (Sheoran and Tewatia, 2017). When studied in ruminants, 
organic acids have been shown to improve rumen fermentation, maintain rumen pH, have a 
buffering effect in the rumen, decrease methane production, and lower harmful bacteria on the 
intestinal wall (Callaway and Martin, 1996; Khampa et al., 2006). Furthermore, organic acids have 
been demonstrated to improve cattle overall health and production (Kung et al., 1982; Khampa et 
al., 2006). Some examples of organic acids include aspartate, malate, and fumarate (Callaway and 
Martin, 1996). 
 Bacteriophages 
Bacteriophages are viruses that infect bacteria (Dias et al., 2013). They are very selective 
to one species of bacteria; therefore, cocktails are often used to inhibit bacteria (Chan et al., 2013; 
Kakasis and Panitsa, 2019). However, bacteriophages are capable of transmitting antimicrobial 
resistance genes (Kakasis and Panitsa, 2019). There are two main types of bacteriophages, lytic 
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and lysogenic (Kakasis and Panitsa, 2019). Lytic bacteriophages propagate inside the cell, burst 
the cell, and release bacteriophage progeny to infect more bacteria (Saha and Mukherjee, 2019). 
However, lysogenic, or temperate, bacteriophages integrate into the bacterial DNA and are then 
called prophages (Selle et al., 2020). The prophages replicate with the bacterial DNA until the 
bacteria become stressed, and then the bacteriophages lyse and kill the host bacterial cell (Machuca 
et al., 2010).   
Bacteriophages can also be genetically modified. These bacteriophages have been 
engineered to re-sensitize bacteria to antimicrobials or deliver molecules with antimicrobial 
activity (Libis et al., 2014). Furthermore, some bacteriophages have been engineered to be less 
specific and more virulent (Pires et al., 2016). Currently, several genetically modified 
bacteriophages are being investigated (Pires et al., 2016).  
Additionally, endolysins, or lysins, are the enzymes bacteriophages use to lyse bacterial 
cells (2017). Lysins are typically heat-stable hydrolases that degrade bacterial peptidoglycan 
(Fischetti, 2008; Parisien et al., 2008). Research has been done on the antimicrobial activity of 
lysins extracted from the bacteriophage (Fischetti, 2008). These studies have shown greater 
antimicrobial activity against Gram-positive bacteria, but endolysins have also been shown to 
inhibit Gram-negative bacteria (Fischetti, 2018). 
 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), in conjunction with 
CRISPR-associated (Cas) proteins, have the potential to be used as an antibiotic alternative. 
CRISPR-Cas proteins are endonucleases that are naturally produced by bacteria and are used as a 
defense mechanism against foreign nucleic acids, such as bacteriophages (Makarova et al., 2006; 
Brouns et al., 2008; Josiane et al., 2010).  There are many different CRISPR-Cas proteins, but 
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CRISPR-Cas9 is the most well studied. CRISPR-Cas9 is a class II CRISPR-Cas endonuclease that 
is guided by RNA and cleaves double-stranded DNA (Elitza et al., 2011; Jinek et al., 2012). 
Cleavage is caused by complementary base pairing of the target DNA with a programmable single 
guide RNA (sgRNA) followed by a necessary protospacer adjacent motif (PAM) sequence in the 
target DNA (Jinek et al., 2012; Shah et al., 2013; Doudna and Charpentier, 2014). The PAM 
sequence binding after complementary base pairing of the target DNA is necessary for the double-
stranded cleavage of the target DNA (Gasiunas et al., 2012; Jinek et al., 2012; Sternberg et al., 
2014). Furthermore, CRISPR-Cas9 has been shown to edit bacterial genomes; therefore, CRISPR-
Cas9 paired with an efficient delivery method will potentially replace many antibiotics (Cong et 
al., 2013; Gomaa et al., 2014; Robert et al., 2014; Moreb et al., 2017). Due to CRISPR- Cas9’s 
ability to efficiently cleave targeted DNA strands, the protein complex has the potential to cleave 
and disrupt a gene in targeted bacteria effectively. 
A significant obstacle will be delivering the CRISPR- cas9 complex into bacteria. Two 
possible delivery methods are via nanoparticles and bacteriophages. Nanoparticles are microscopic 
particles with varying properties that benefit therapeutic use in the health industry (Anu Mary Ealia 
and Saravanakumar, 2017). Lipid and polymeric-based nanoparticles have been researched with 
CRISPR-Cas9 for therapeutic use in treating cancer and genetic disorders (Chen et al., 2017; Lee 
et al., 2018). The second delivery method is the use of bacteriophages, which are bacterial viruses 
that insert DNA into a bacterial host. Bacteriophages have two possible life cycles: lytic or 
lysogenic (Snyder, 2013). Lytic bacteriophages lyse bacterial cells, while lysogenic 
bacteriophages insert their DNA into bacterial cells' genome (Snyder, 2013). Lysogenic 
bacteriophages have been used to insert CRISPR-Cas9 into Escherichia coli and Staphylococcus 
aureus in vitro (David et al., 2014; Robert et al., 2014; Yosef et al., 2015). The main difference 
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between the two delivery methods is that nanoparticles do not have target specificity unless a 
modality is added to make them specific, and they can be easily modified, while most 
bacteriophages have species-specific specificity and can be more difficult to modify (Carl et al., 
2003; Lino et al., 2018). Due to the specificity of CRISPR-Cas9, delivery to more than the target 
bacteria should not cause other, possibly beneficial bacteria to be affected as long as the gRNA is 
properly designed (Jinek et al., 2012; Cong et al., 2013). 
 Other antimicrobial alternatives  
 Probiotics  
Probiotics are live cultures of microorganisms that work mainly by competitive exclusion 
and colonization, leading to increased beneficial microbes in the rumen and intestines (Ballou et 
al., 2019). Probiotics have been shown to increase cattle health and performance (Uyeno et al., 
2015). Studies have demonstrated increased average daily gain, increased feed to gain ratio, and 
improved milk production in cattle fed probiotics (Uyeno et al., 2015; Dailidavičienė et al., 2018; 
Kelsey and Colpoys, 2018). However, probiotics can carry antimicrobial resistance genes and 
spread them to other bacteria (Egervärn et al., 2009).  
 Prebiotics  
Prebiotics are feed ingredients digestible by microbes found in the rumen and intestines 
(Manning and Gibson, 2004). They are fed to selectively stimulate a more beneficial microbial 
community (Manning and Gibson, 2004; Ballou et al., 2019). Prebiotics enrich beneficial bacteria 
in the rumen and intestines, thus competitively inhibiting harmful bacteria (Callaway et al., 2014).  
By enriching beneficial bacteria, probiotics assist in improving cattle health and increasing 




Microminerals are essential to health and growth of cattle.  Some microminerals are used 
in higher concentrations in the diet to improve overall cattle health and increase growth promotion 
(Jacob et al., 2010). Moreover, high concentrations of microminerals can be cytotoxic to bacteria 
(Abou-Shanab et al., 2007). However, bacteria are becoming resistant to metals, and their 
resistance genes are associated with resistance genes to multiple antimicrobials (Amachawadi, 
2014; 2017). Some examples are copper and zinc (Zhang et al., 2011).  
 Antimicrobial Peptides 
Many organisms produce antimicrobial peptides (AMPs) to protect against pathogens 
(Wang et al., 2019). They interact with the bacterial cell membrane and cause it to disintegrate, 
leading to cell death (Powers and Hancock, 2003; Wang et al., 2019). Researchers have shown 
that they are typically broad-spectrum and are active against multidrug-resistant pathogens 
(Powers and Hancock, 2003; Barksdale et al., 2016). However, resistance to AMPs has been 
documented, but bacteria do not easily develop resistance (Gunn, 2001; Peschel and Vincent 
Collins, 2001; Wang et al., 2019). 
Bacteriocins are AMPs produced by bacteria that inhibit competing bacteria, including 
antimicrobial-resistant bacteria (Meade et al., 2020). These have three classes. Class I, less than 
five kDa; Class II, between 5-10 kDa; and Class III, over 30 kDa (Meade et al., 2020). Many 
bacteriocins can inhibit bacteria by inhibiting peptidoglycan biosynthesis and translation, along 
with the typical mode of action of AMPs, cell membrane disintegration (Imke et al., 2001; Meade 
et al., 2020). Furthermore, bacteriocins can withstand harsh environmental conditions (Perez et al., 
2014; Meade et al., 2020).  
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 Predatory Bacteria 
Predatory bacteria prey on a variety of Gram-negative bacteria (Stolp and Starr, 1963; 
Lambina et al., 1983). They attack other bacteria by attaching, entering the periplasmic space, 
consume nutrients from and replicate inside the bacterium they have entered, and eventually lyse 
the bacterium (Riccardo et al., 2015). Bdellovibrio bacteriovorus and Micavibrio aeruginosavorus 
are two commonly studied species of predatory bacteria (Riccardo et al., 2015). They have been 
demonstrated to inhibit multi-drug resistant Gram-negative bacteria such as Pseudomonas 
aeruginosa, Escherichia coli, and Klebsiella pneumoniae (Dashiff et al., 2011). 
 Immune Modulators  
Immune modulators enhance the immune system, making the host more resistant to 
pathogens (Amachawadi, 2014). They cause a passive immune response via administration of 
antibodies, cytokines, egg yolk, or dried plasma (Amachawadi, 2014; 2017).  Immune modulators 
have been demonstrated to have growth-promoting effects similar to antimicrobials (Coffey and 
Cromwell, 1995; Chae et al., 1999).  
 Vaccines  
Vaccines stimulate a protective immune response and are used to prevent diseases (2017). 
Vaccines are typically a dead or modified version of a pathogen that is injected into an animal. 
This causes the animal’s immune system to create antibodies against the pathogen. Furthermore, 
studies have shown some vaccines to improve animal productivity and performance.    
 Synthetic Mimics of Antimicrobial Peptides (SMAMPs) 
Synthetic mimics of antimicrobial peptides are designed to mimic the properties of 
antimicrobial peptides (Scorciapino and Rinaldi, 2012). There are three major approaches to 
designing SWAMPS (Ghosh et al., 2019). One approach is to use peptidomimetic oligomers which 
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have modifications in the peptide backbone of AMPs (Ghosh et al., 2019). Their antimicrobial 
activity mostly comes from the secondary structures they form. Currently, oligoureas, beta-
peptides, alpha-AA peptides, oligoacyl-lysines, and peptoids are being studied as potential 
antimicrobial alternatives (Ghosh et al., 2019). Another method is to use synthetic antimicrobial 
polymers. These polymers have hydrophobic and cationic domains incorporated to give them 
antimicrobial activity (Huang et al., 2016; Konai et al., 2018). The third major approach is the use 
of  small molecules. Small molecules are derivatives of larger molecules that are synthetically 
manipulated to mimic the properties of AMPs (Ghosh et al., 2019). Currently, brilacidin, AMC-
109, ceradenins, binaphthyl-based dicationic compounds, xanthone derivatives, aryl-alkyl-lysines, 
biphenyl-based lysine derivatives, and norspermidine-based compounds are being studied as 
potential antimicrobial alternatives (Ghosh et al., 2019). 
 Innate Defense Regulatory (IDR) Peptides 
Innate defense regulatory peptides have been designed with antiendotoxin and 
immunomodulatory activities but no antibacterial activity (Hilchie et al., 2013). Interestingly, IDR 
peptides have demonstrated the ability to protect mice from Gram-negative and Gram-positive 
bacterial infections and have completed clinical trials (Mansour et al., 2015; Ghosh et al., 2019). 
 Antibacterial oligonucleotides 
Antibacterial oligonucleotides are designed to silence essential and antimicrobial 
resistance genes with antisense oligonucleotides like phosphorothioate oligodeoxynucleotides 
(Ghosh et al., 2019). They have demonstrated antimicrobial activity against various bacterial 




Nanoparticles have been shown to have antimicrobial properties at small doses (Durazzo 
et al., 2020). Nanoparticles have two significant modes of action, which are the production of 
oxygen-free radicals and disrupting membrane potential and integrity, although some 
nanoparticles inhibit bacteria by inhibiting enzymes, producing reactive nitrogen species, or 
inducing bacterial cell death (Beyth et al., 2015). Furthermore, nanoparticles can be used to deliver 
antimicrobials and antimicrobial alternatives to bacteria (Gao et al., 2018).  
Inorganic and organic nanoparticles are the two major categories of nanoparticles (Beyth 
et al., 2015). Inorganic nanoparticles are comprised of metals and metal oxides (Beyth et al., 2015). 
These nanoparticles typically inhibit bacteria by producing oxygen-free radicals (Jin et al., 2009; 
Liu et al., 2009; Pelgrift and Friedman, 2013; Pati et al., 2014; Beyth et al., 2015). Some examples 
of inorganic nanoparticles with antimicrobial properties are silver, titanium oxide, zinc oxide, iron 
oxide, gold, copper oxide, magnesium oxide,  nitric oxide, and aluminum oxide (Wei et al., 1994; 
Lellouche et al., 2009; Hamal et al., 2010; Zhao et al., 2010; Ansari et al., 2012; Carpenter and 
Schoenfisch, 2012; Lellouche et al., 2012; Schairer et al., 2012; Zhigang et al., 2012; Pelgrift and 
Friedman, 2013; Anghel et al., 2014; Ansari et al., 2014; De Simone et al., 2014; Majdalawieh et 
al., 2014; Palanikumar et al., 2014; Poulose et al., 2014; Beyth et al., 2015). Organic nanoparticles 
are less stable than inorganic molecules (Beyth et al., 2015). These are cationic molecules that 
have multiple mechanisms of action, most of which result in membrane disruption and cell death 
(Denyer and Stewart, 1998; Nurit et al., 2010; Huh and Kwon, 2011; Ibrahim et al., 2014; Beyth 
et al., 2015). Poly-ε-lysine, quaternary ammonia compounds, N-Halamine compounds, 
polysiloxanes, quaternary phosphonium groups, quaternary sulfonium groups, 5-Chloro-8-
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hydroxy-quinoline, polycationic nanoparticles, and chitosan are examples of organic nanoparticles 
(Nonaka et al., 2003; Rabea et al., 2003; Sauvet et al., 2003; Beyth et al., 2015). 
 Antibiotic Inactivators 
Antibiotic inactivators are genetically engineered enzymes that degrade antibiotics (Ghosh 
et al., 2019). These are being studied for use with bacterial infections, like C. difficile, where 
antibiotic use increases infection risk (Kokai-Kun et al., 2017). They work by degrading or 
inhibiting the antibiotic so the normal microflora can reestablish quicker and competitively 
exclude the infection-causing pathogenic bacterium (Therrien and Levesque, 2000; Kokai-Kun et 
al., 2019). 
 Conclusion 
In conclusion, there are two main concerns with antimicrobial use in cattle production. The 
primary concern is antimicrobial resistance, while the lesser is alteration of the rumen microbiome. 
Antimicrobial resistance is a major threat to the health of both livestock and humans. However, 
microbiome alterations are a more significant concern in human medicine than in cattle production. 
This is because most alterations on the rumen microbiome benefit cattle productivity, while most 
alterations of the human microbiome can increase the risk for many diseases. These concerns have 
led to research on many different antimicrobial alternatives. Each alternative has its strengths and 
weaknesses. Some antimicrobial alternatives are on the market for use in cattle, while others are 
still being researched. Research on antimicrobial alternatives for use in cattle production must 
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Chapter 2 - General Introduction 
Antimicrobial agents are used to treat or prevent bacterial infections. In recent years, there 
has been an increased emphasis on effective disease prevention and management in food animal 
production because of the need to feed a growing global population (Mathew et al., 2007; 
Amachawadi, 2014). In cattle, antimicrobials are used more often to treat or prevent respiratory 
disease complex and liver abscesses in feedlot cattle and mastitis in dairy cows.  
Bovine respiratory disease (BRD) complex is of major economic concern to cattle 
producers because of morbidity and mortality (Bach, 2011; Teixeira et al., 2017; Dunn et al., 2018; 
Holschbach et al., 2020). Bacterial pathogens associated with BRD infections are Pasteurella 
multocida, Mannheimia haemolytica, Histophilus somni, and Mycoplasma bovis (Apley, 2006; 
DeDonder, 2016). Macrolides, florfenicol, fluoroquinolones, tetracyclines and 3rd generation 
cephalosporins are commonly used antimicrobials for the treatment and prevention of BRD in 
cattle (USDA, 2018). 
Liver abscesses are also of major economic concern in beef cattle production. In addition 
to liver condemnations in beef processing plants (Eastwood et al., 2017), liver abscesses cause 
decreased animal performance and lower carcass yield and quality (Nagaraja and Lechtenberg, 
2007). The primary causative agent is Fusobacterium necrophorum, an anaerobic and Gram-
negative, rod-shaped opportunistic pathogen that is part of the rumen microbiota (Langworth, 
1977). The species is further categorized into two subspecies, necrophorum and funduliforme, 
which differ in a number of characteristics, including virulence. The subsp. necrophorum is more 
frequently involved in causing liver abscesses than subsp. funduliforme (Tadepalii et al. 2008). 
Currently, tylosin, a macrolide, is most commonly used in the feed to reduce the incidence of liver 
abscesses (Nagaraja and Lechtenberg, 2007).  
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Bovine mastitis is a major production disease of dairy cows with significant economic 
impact. Mastitis causes reduced milk yield and is caused by a number of  bacterial pathogens, 
mainly Staphylococcus aureus, Streptococcus agalactiae, S. dysgalactiae, S. uberis, Pseudomonas 
aeruginosa, Klebsiella pneumoniae, and Escherichia coli (DeGraves and Fetrow, 1993; Hortet and 
Seegers, 1998; Gianneechini et al., 2002; Gröhn et al., 2004; Park et al., 2014). Beta-lactams, 
macrolides (erythromycin) and lincosamides (pirlimycin) are the common antimicrobials used for 
mastitis prevention and treatment (Ma et al., 2021).  
Additionally, foodborne illnesses are a major public health concern and food animals are 
carriers for many food-borne pathogens. Three major foodborne bacterial pathogens of cattle are 
Shiga toxin-producing E. coli, Salmonella enterica, and Campylobacter jejuni. The most common 
antimicrobials used to treat Salmonella and Campylobacter coli food-borne infections are 
ciprofloxacin, cephalosporins, trimethoprim/sulfamethoxazole, and azithromycin (Switaj et al., 
2015). However, antimicrobial use is not recommended for infections caused by Shiga toxin 
producing E. coli because antimicrobial use can increase the risk of hemolytic uremic syndrome 
(Wong et al., 2012).  
Antimicrobial resistance to antimicrobials, particularly to medically important 
antimicrobials such as cephalosporins and macrolides, has become a major public health concern 
(FDA, 2012, 2015; Torio and Padilla, 2018; WHO, 2019). Antimicrobial resistance occurs when 
a bacterium changes and survives in the presence of an antimicrobial. The use of antimicrobials 
can select for resistant bacterial strains that can transfer resistance genes to other bacteria (Holmes 
et al., 2016). For example, Tenhagen et al. (2014) reported 631 antimicrobial resistant isolates of 
S. aureus from various cattle production areas. Isolates of Escherichia coli, Klebsiella 
pneumoniae, and Pseudomonas aeruginosa have similarly shown resistance to multiple 
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antimicrobials (Liu et al., 2013). Likewise, Karama et al. (2020) demonstrated that 52.3 % of 86 
Campylobacter isolates were resistant to one or more antimicrobials and of those 32.5 % were 
multidrug resistant. Clindamycin, nalidixic acid, tetracycline, erythromycin, azithromycin, 
florfenicol, gentamicin, telithromycin, and ciprofloxacin were among the antimicrobials that the 
Campylobacter isolates become resistant to (Karama et al., 2020). Furthermore, Salmonella 
isolates have been demonstrated to be resistant to multiple antimicrobials (Foley and Lynne, 2008). 
Antimicrobial resistance to ceftiofur and ceftriaxone in Salmonella isolates is concerning because 
both antimicrobials are third generation, and broad-spectrum cephalosporins and ceftriaxone are 
used in treatment of food-borne Salmonella infections in humans (Douris et al., 2008; Switaj et 
al., 2015). Resistance genes for tetracyclines, fluoroquinolones, beta-lactams, macrolides, 
sulfonamides, lincosamides, phenicols, and aminoglycosides have been reported in bacterial 
pathogens (P. multocida, M. haemolytica, H. somni, and M. bovis) associated with BRD (O'Connor 
et al., 2010; D’Amours et al., 2011; Desmolaize et al., 2011; Kadlec et al., 2011; Katsuda et al., 
2012; Michael et al., 2012; Alexander et al., 2013; Pardon et al., 2013).  
Macrolides are medically important antimicrobials, therefore, antimicrobial resistance to 
macrolides is a major public health concern. Tylosin, a macrolide, is exclusively used in animals, 
but is structurally similar to erythromycin. Therefore, there is concern with the use of tylosin in 
animals, which is the reason for placing tylosin under veterinary oversite with the Veterinary Feed 
Directive (FDA, 2021). The influence of tylosin use on antimicrobial resistance to macrolides and 
potential spread to other bacteria through horizontal transfer, has been studied (Zaheer et al., 2013; 
Alicia et al., 2015; Müller et al., 2018). Recent studies on tylosin in the feed of feedlot cattle to 
prevent liver abscesses have investigated AMR of gut bacteria and F. necrophorum. These studies 
concluded that there was no evidence of macrolide resistance in F. necrophorum isolates and only 
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an occasional increase in macrolide-resistant fecal enterococci was detected (Nagaraja et al., 1999; 
Amachawadi et al., 2017; Schmidt et al., 2020). These results indicate minimal AMR impact of 
administering in-feed tylosin to prevent liver abscesses. Still, there is considerable interest in 
finding alternatives to replace tylosin because of the public health concern of using a medically 
important antibiotic in cattle diets. Tylosin alternatives that have been examined are direct-fed 
microbials (Huebner et al., 2019), oil seeds (Mir et al., 2008), egg yolk immunoglobulins (Stotz et 
al., 2021), essential oils (Elwakeel et al., 2013), and vaccines (Fox et al., 2009). Vaccines have not 
been able to replace tylosin in the feedlot industry because there has been minimal efficacy at 
reducing liver abscesses (Checkley et al., 2005). Likewise, direct-fed microbial products that use 
yeast have been shown to decrease severity, but not overall prevalence of liver abscesses in feedlot 
cattle (Shen et al., 2019). 
Antimicrobial alternatives have also been researched on other common cattle pathogens, 
such as E. coli, Salmonella, and S. aureus. Some of these alternatives are antimicrobial peptides 
(Wang et al., 2019), innate defense regulatory (IDR) peptides (Mansour et al., 2015), antimicrobial 
oligonucleotides (Ayhan et al., 2016), nanoparticles (Beyth et al., 2015), bacteriophages (Kakasis 
et al., 2019), CRISPR-Cas (Cong et al., 2013), and plant extracts (2018) Bacteriophages are 
bacterial viruses that are typically specific to one bacterial species. They have been proven to 
greatly inhibit bacteria, but resistance is common and therefore cocktails are typically made to 
treat pathogenic bacteria (Ghosh et al., 2019; Saha and Mukherjee, 2019; Shlezinger et al., 2017). 
Furthermore, clustered regularly interspaced short palindromic repeats (CRISPR) in conjunction 
with CRISPR-associated proteins (Cas) have been demonstrated to reduce antimicrobial resistant 
bacteria and inhibit bacteria through cleaving bacterial DNA, leading to removal of plasmid 
carrying resistance genes or bacterial cell death (Beisel et al., 2014; Bikard et al., 2014; Buckner 
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et al., 2018). Plant extracts, such as essential oils and phenolic compounds, have also been shown 
to inhibit bacterial pathogens (Villalobos et al., 2016). For example, Kil et al. (2009) described the 
minimum inhibitory concentrations (MIC) for a phenolic compound on S. aureus, Salmonella 
Typhimurium, K. pneumoniae, and E. coli of 250, 500, 500, and 250 µg/mL, respectively,  
Therefore, our main objectives were to evaluate antimicrobial alternatives to inhibit or 
reduce population density of F. necrophorum in the rumen, as well as inhibit foodborne pathogens 
and pathogens involved in bovine mastitis. The alternatives evaluated to inhibit or reduce F. 
necrophorum were bacteriophages and CRISPR-Cas, and sorghum phenolic compounds to control 
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Chapter 3 - Relative Isolation Rates of Bacteriophages Lytic to 
Fusobacterium necrophorum of Liver Abscess Origin from Ruminal 
Fluid and City Sewage Samples 
 Abstract 
Fusobacterium necrophorum subsp. necrophorum, an anaerobic ruminal bacterium is the 
primary causative agent of liver abscesses in feedlot cattle. Currently, tylosin, a macrolide, is 
widely used as a feed additive to reduce the incidence of liver abscesses. Because of the public 
health implication associated with the use of a medically important antimicrobial in food animal 
production system, there is considerable interest in finding an antimicrobial alternative to control 
liver abscesses. Bacteriophages that specifically target and lyse Fusobacterium have the potential 
to replace tylosin for the control of liver abscesses. Our objective was to detect and isolate 
bacteriophages lytic to F. necrophorum subsp. necrophorum. Pooled bovine ruminal fluids from 
slaughtered cattle at abattoirs and pooled untreated city sewage samples were collected on five 
separate dates. A total of 68 F. necrophorum subsp. necrophorum strains, isolated from liver 
abscesses, were used to isolate bacteriophages. Aliquots of pooled ruminal fluid or sewage samples 
were incubated anaerobically overnight with lysine and subsp. necrophorum strains, filtered, 
bacteria-free filtrates were spotted on lawns of the strains, and presence of plaques were considered 
as positive for phages. Presumptive bacteriophage plaques were harvested, and the viruses purified 
by serial passaging on the susceptible bacterial strains. The bacteriophage isolation frequencies 
were compared between sample types, sampling dates, and F. necrophorum strains. The overall 
relative frequency of isolated bacteriophages lytic to F. necrophorum subsp. necrophorum was 
17.1 %. The frequency of bacteriophage isolation between collection dates ranged from 0 to 25.4 
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% for ruminal fluid, and from 13.7 to 32.0 % for sewage samples. The frequency of isolation of 
bacteriophages lytic to F. necrophorum subsp. necrophorum from sewage samples was higher (p 
< 0.0001) than lytic bacteriophages isolated from bovine ruminal fluid samples. Bacteriophages 
were isolated more frequently with certain F. necrophorum subsp. necrophorum strains than 
others. Bacteriophages have the potential to be used as feed additives to reduce the population 
density of F. necrophorum subsp. necrophorum in the rumen, thereby reduce the incidence of liver 
abscesses. 
 Introduction 
Liver abscesses are one of the major reasons for liver condemnations in beef cattle processing 
plants. According to the recent National Beef Quality Audit, abscesses accounted for 58 % of all 
condemned livers (Eastwood et al., 2017). Additionally, liver abscesses contribute to the economic 
loss to the cattle industry due to decreased animal performance and lower carcass yield and quality, 
as well as time and labor costs associated with handling liver abscesses at the slaughter plant 
(Nagaraja and Lechtenberg, 2007). Fusobacterium necrophorum, an anaerobic, Gram negative, 
rod-shaped opportunistic pathogen, is the primary causative agent of liver abscesses (Langworth, 
1977). The bacterium is a member of the microbial community of the rumen and travels across the 
ruminal epithelium into the portal circulation to the liver to produce abscesses. Chronic ruminal 
acidosis in cattle fed high grain diets compromises ruminal epithelium and permits F. 
necrophorum to penetrate the ruminal wall to cause ruminal abscesses and rumenitis.  From these 
abscesses, the bacterium enters the portal blood to reach the liver (Nagaraja and Chengappa, 1998). 
Two subspecies, necrophorum and funduliforme, are reported, which differ in colony and cell 
morphologies, growth patterns in broth, and more importantly, in virulence (Tadepalli et al., 2009). 
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The subsp. necrophorum is more virulent, hence, more frequently involved in liver abscesses than 
the subsp. funduliforme (Tadepalli et al., 2009).  
Currently, the antibiotic tylosin is used in the feed to reduce the incidence of liver abscesses 
(Nagaraja and Lechtenberg, 2007). Use of in-feed tylosin is of concern because the antibiotic, 
although used exclusively in animals, belongs to the macrolide class of antimicrobials, a class 
considered as a medically important antimicrobial (FDA, 2019). Because of the public health 
concern associated with medically important antimicrobial use in feedlot cattle there is 
considerable interest in finding an alternative to replace tylosin use. 
 Bacteriophages are viruses that infect bacteria and are either lytic or lysogenic (Snyder, 2013). 
Originally, phages were investigated as potential therapeutic agents against human and animal 
infections (Waldor et al., 2005). In recent years, the therapeutic use of phages or phage therapy, 
has regained interest as an alternative to antimicrobial therapy (Czaplewski et al., 2016; Gadde et 
al., 2017; Fischetti, 2018). Bacteriophages have been used in food animal processing plants to 
control for foodborne pathogens (Bruce and James, 2004; Housby and Mann, 2009; Tang et al., 
2009; Bhardwaj et al., 2015). Although F. necrophorum is a major bovine pathogen, there is only 
one report on the isolation of bacteriophages lytic to this bacterium (Tamada et al., 1985). 
However, bacteriophages have been isolated from other species of Fusobacterium, such as 
nucleatum, a human oral pathogen (Andrews et al., 1997; Machuca et al., 2010). Here, we report 
on the relative frequency of isolation of bacteriophages lytic to F. necrophorum subsp. 
necrophorum from ruminal fluid and city sewage samples. 
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 Materials and Methods 
 F. necrophorum Strains 
 A total of 68 F. necrophorum subsp. necrophorum strains, previously isolated from liver 
abscesses of beef cattle, were used for phage detection and isolation (Amachawadi et al., 2017). 
Of the 68 strains, 65 were used for bacteriophage isolation from ruminal fluid and 56 were used 
for isolation from city sewage samples. Fifty-three strains were used for both sample types, while 
12 strains were used for isolation from ruminal fluid samples only and three were used for isolation 
from city sewage samples only. The strains, stored at -80°C, were streaked onto sheep blood agar 
plates (SBA; Remel Inc., Lenexa, KS) and incubated at 37° C for 48 h in an anaerobic glove box 
(Forma Scientific Inc., Marietta, OH). Single colonies of each isolate were inoculated into 10 ml 
pre-reduced (with 0.05 % cysteine HCl; Sigma-Aldrich, St. Louis, MO), anaerobically sterilized 
brain heart infusion broth (PRAS-BHI; Becton Dickinson, Sparks, MD) and incubated overnight 
at 37°C. 
 Collection of Ruminal Fluid and City Sewage Samples 
Ruminal fluid samples were collected at a beef cattle packing plant in the Midwest on five 
different dates between July 2019 and November 2019. At each visit, over a period of 4 to 6 hours, 
3 liters of pooled ruminal fluid samples from squeezed ruminal contents from cattle originating 
from at least five different feedlots were collected and transported in tightly capped thermos 
containers kept on ice to the laboratory. Sewage samples were collected at a wastewater treatment 
plant on five different dates between October 2019 and February 2020. At each visit, 3 liters of 
untreated sewage samples were collected and transported to the laboratory. Ruminal fluid and 
sewage samples were placed in anaerobic jars and kept in a refrigerator and processed the next day 
for bacteriophage isolation. 
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 Isolation of Bacteriophages 
One hundred milliliters of ruminal fluid or sewage sample was aliquoted into twelve 125 mL 
flasks and 0.73 g L-lysine (Sigma-Aldrich, Burlington, VT) and 3.7 g of dehydrated BHI powder 
(Beckton Dickinson) were added and mixed until dissolved (Russell, 2005). The flasks were placed 
in an anaerobic glove box and 1 mL of three to five randomly selected F. necrophorum strains 
were inoculated into each flask. The flasks were placed on a shaker for overnight incubation at 37 
C. The following day, 1 mL from each flask was pipetted into an Eppendorf tube (Eppendorf AG, 
Hamburg, Germany) and centrifuged at 12,000 x g for 2 minutes.  Five hundred microliters of each 
supernatant were then pipetted into two mL Spin-X centrifuge tubes (Corning Costar, Corning, 
NY) with a 0.22 µm pore size membrane filter and centrifuged at 12,000 x g for 2 minutes.  
Supernatant from the Spin-X tube was pipetted into a 0.22 µm syringe filter and filtered a second 
time.  Twenty microliters of the filtrate were then diluted in 180 mL of sterile SM buffer (G-
Biosciences, St. Louis, MO) in a 1.5 mL Eppendorf tube. Individual bacterial cultures were spread-
plated on BAP with sterile cotton swabs to obtain bacterial lawns and 20 µL of the corresponding 
flask filtrates and dilutions were spotted onto each plate.  The plates were placed agar side down 
in an anaerobic glove box and incubated at 37°C overnight. The next day, the bacterial lawns were 
checked for phage plaques (Figure 3.1a). The plaques were then harvested by pipetting the agar 
where the spot was with a transfer pipette so that the agar was pipetted into the transfer pipet and 
was transported into 500 µL sterile SM buffer in 1.5 mL Eppendorf tubes. This was allowed to 
elute overnight at 37°C in an anaerobic glove box. The following day, the buffer with harvested 
bacteriophages was centrifuged for 30 seconds at 12,000 x g and the supernatant was transferred 
to a sterile Spin- X tube with a 0.22 µm filter before being centrifuged at 12,000 x g for 2 minutes. 
The filtrates were serially diluted 10-fold in SM buffer and 100 µL of each dilution was mixed 
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with 100 µL of the corresponding F. necrophorum strain. This mixture was spread plated onto pre-
labeled blood agar plates. Bacterial lawns were checked for the presence of single plaques and 
these single plaques were then harvested as described above (Figure 3.1b). If multiple plaque 
morphologies were observed, each morphologically different plaque was harvested separately. The 
filtrates were diluted two times as described above and each dilution was spotted onto a new lawn 
of the corresponding F. necrophorum strain. Bacterial lawns were checked for the presence of 
plaques and then harvested as previously described (Figure 3.1c). The following day, 100 µL of 
the bacteriophage isolate was then distributed into two cryovials, each containing 300 µl 20 % 
glycerol and stored in a -80 °C freezer.  
 Statistical Analysis 
The frequency of F. necrophorum bacteriophage isolation was estimated as the proportion of 
samples testing positive for the presence of bacteriophage divided by the total number of F. 
necrophorum strains tested. Prevalence of bacteriophage was stratified by sample type, sampling 
day, and F. necrophorum strains used for isolation. Crude associations between frequency of 
sample type or sampling date were tested via the likelihood-ratio based Chi-square test or the 
Fisher’s exact test. Descriptive statistics were obtained for each strain per sample type. The results 
were analyzed using STATA ver 16.1 (StataCorp, 2019 #747). The results of the bacteriophage 
isolation, presence or absence, were the outcome variable. Associations between the isolated 
bacteriophages and sample types or sampling days were tested with multivariable random effects 
logistic regression models in considering F. necrophorum strains identifier as potential clustering 
variable to account lack of independence associated with testing F. necrophorum strains for sample 
type on multiple sampling days. All possible two-way interactions between individual explanatory 
variables were assessed at significance level p < 0.05. The Wald type test was used to assess the 
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statistical significance of association between the outcome and each explanatory variable or two- 
way interaction between variables. An explanatory variable or two-way interaction between 
variables was considered significant at p-value of 0.05. Odds ratio (OR) and their respective 95 % 
confidence interval were used to evaluate the probability between outcome and explanatory 
variable in the model. Regression model diagnostics including normality of predicted values of the 
random variables (or best linear unbiased predictors-BLUPS) and Pearson and Deviance residuals 
for observation at the lower level (sample level) from the final multivariable models. Relative 
frequencies were determined by dividing the number of isolated bacteriophages by the total 
number of samples. The frequency of isolation was determined for sample collection dates, pooled 
ruminal and sewage samples, pooled total samples, and individual F. necrophorum strains. 
 Results 
Overall, a total of 89 bacteriophages lytic to F. necrophorum subsp. necrophorum were 
isolated from 5 different sampling days from both sample types and 65 strains of F. necroporum 
subsp. necrophorum. For ruminal fluid samples, the bacteriophage isolation frequency between 
collection dates ranged from 0 to 25.4 %, while the relative frequencies of bacteriophage isolation 
from sewage ranged from 13.7 to 32.0 % (Table 3.1). The frequency of isolation of bacteriophages 
lytic to F. necrophorum subsp. necrophorum from city sewage samples was higher (p < 0.0001) 
than lytic bacteriophages isolated from bovine ruminal fluid samples. Furthermore, bacteriophages 
isolated from sewage had a 0.9 log odds increase compared to bacteriophages isolated from 
ruminal fluid (p < 0.0001). There were no differences between sewage collection dates (p = 
0.2909), but differences between ruminal fluid collection dates were significant (p = 0.0091). 
Bacteriophages were isolated more frequently with certain F. necrophorum subsp. 
necrophorum strains than others (Tables 3.2 and 3.3). Of the 65 strains used with ruminal fluid, 
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22 strains yielded bacteriophages and 43 did not. In the case of sewage samples, 26 strains did not 
yield bacteriophages, while 33 strains yielded bacteriophages, and three strains yielded 
bacteriophages at each collection date (Table 3.2). Overall, 40 strains of F. necrophorum yielded 
bacteriophages with either ruminal fluid or sewage sample in one or more of the sampling dates 
(Table 3.3). Thirteen strains yielded bacteriophages from both ruminal fluid and sewage samples, 
whereas 8 strains yielded bacteriophages from ruminal fluid and 17 strains yielded from sewage 
sample only (Table 3.4). The overall relative frequency of isolation of bacteriophages for three F. 
necrophorum subsp. necrophorum strains (2016-13-11, 2016-13-29, and 2016-13-69) were 6/10, 
6/10, and 6/7 or 60 %, 60 %, and 85.7 %, respectively (Table 3.3). For two strains (2016-13-11 
and 2016-13-29), the relative frequencies of isolating bacteriophages in bovine ruminal fluid and 
city sewage samples were 1/5 and 5/5 or 20 % and 100 %, respectively. The third strain (2016-13-
69) had relative frequencies of isolating bacteriophages in bovine ruminal fluid and city sewage 
samples of 1/2 and 5/5 or 50 % and 100 %, respectively. The overall relative frequency of isolating 
bacteriophages from this F. necrophorum subsp. necrophorum strain (2016-13-69) was the highest 
at 5/7 (85.7 %). No F. necrophorum subsp. necrophorum strains had a relative frequency of 
isolating bacteriophages over 50 % from bovine ruminal fluid, while nine F. necrophorum subsp. 
necrophorum strains had relative frequencies of isolating bacteriophages over 50 % and three of 
these were 100 % from city sewage samples. 
 Discussion 
Currently, the available method to control liver abscesses is with the use of antimicrobial feed 
additives. Five antimicrobial compounds have FDA approval for use in the feed to control liver 
abscesses in the US (Feed Additive Compendium, 2021). The most widely used antibiotic is 
tylosin, which belongs to the antimicrobial class, macrolide.  (Nagaraja and Chengappa, 1998). 
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Tylosin is a narrow spectrum antibiotic, primarily effective against Gram-positive bacteria 
(Gingerich et al., 1977). However, the antibiotic is inhibitory to certain Gram-negative bacteria, 
including F. necrophorum (Tan et al., 1994; Lechtenberg et al., 1998). Although tylosin is used 
exclusively in animals, it is structurally similar to erythromycin, and antibiotics in the macrolides 
class are categorized as medically important because of their extensive use in human medicine 
(Scott et al., 2019). Therefore, there is growing scrutiny in the use of tylosin in animals, which is 
the reason for placing tylosin under the Veterinary Feed Directive with veterinary oversight (FDA, 
2021). The impact of tylosin exposure on antimicrobial resistance of gut bacteria, particularly 
enterococci, which has the propensity for horizontal transfer of AMR genes, is of some concern 
(Zaheer et al., 2013; Alicia et al., 2015; Müller et al., 2018). In a recent study that measured the 
AMR of gut bacteria in feedlot cattle administered with in-feed tylosin to prevent liver abscesses, 
the conclusion was that the AMR impact was minimal and did not extend beyond occasional 
increase in macrolide-resistant fecal enterococci (Schmidt et al., 2020). Interestingly, there is no 
evidence of macrolide resistance in F. necrophorum isolated from liver abscesses of tylosin-fed 
cattle (Nagaraja et al., 1999; Amachawadi et al., 2017). Because of the public health concern 
associated with the use of a medically important antibiotic in cattle diets, there is considerable 
interest in finding alternatives to replace tylosin. Some of the alternatives that have been evaluated 
include vaccines (Saginala et al., 1997; Jones et al., 2004; Fox et al., 2009), essential oils (Meyer 
et al., 2009; Elwakeel et al., 2013; Samii et al., 2016), oil seeds (Mir et al., 2008), egg yolk 
immunoglobulins (Stotz et al., 2021) and direct-fed microbials (Huebner et al., 2019). Because 
virulence factors have been identified and a few have been well-characterized, there have been 
many efforts to develop an efficacious vaccine (Amachawadi and Nagaraja, 2016). Although a 
bacterin is commercially available (Fusogard®; Elanco Animal Health, Greenfield, IN), the 
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efficacy of the vaccine has been shown to be marginal and has not replaced tylosin use in the 
feedlot industry (Checkley et al., 2005). Feeding certain yeast-based commercial direct-fed 
microbial products (Natursafe or XPC, Diamond V, Cedar Rapids, IA) have been shown to reduce 
severity of liver abscesses compared to the control, although the proportion of total abscessed 
livers was not different (Shen et al., 2019). The likely mode of action is alleviation of ruminal 
acidosis by the yeast product (Shen et al., 2018). 
Virulent or lytic bacteriophages are a potential alternative to antimicrobials to treat animal and 
human infections (Waldor et al., 2005). Phage therapy was investigated in the 1920s and 1930s, 
but interest was lost as antibiotics became available (Adams, 1959; Summers, 2012). In recent 
decades, there has been a renewed interest in phage therapy, as data show it could be an effective 
tool against bacterial infections in animal and human medicine (Joerger, 2003; Matsuzaki et al., 
2005; Kutateladze and Adamia, 2010; Ghosh et al., 2019; Saha and Mukherjee, 2019). However, 
limited research has been done on phage therapy for pathogens in animals. The only study reported 
on isolation of bacteriophages lytic to F. necrophorum was by Tamada et al (1985). The study 
reported a single phage isolated and characterized from 54 bovine ruminal fluid samples (Tamada 
et al., 1985). The phage was lytic to both subspecies of F. necrophorum. 
In the phage isolation procedure, we used an enrichment step that included incubation of 
ruminal fluid or sewage samples with lysine and F. necrophorum strains (3 to 5 strains per sample 
aliquot) in order to promote fusobacterial growth and enhance the chance of phage detection. 
Fusobacterium necrophorum utilizes lysine as an energy source and rapidly deaminates it to 
acetate, butyrate, and ammonia (Russell, 2005, 2006). Therefore, addition of lysine to ruminal 
fluid and sewage samples, enriches the fusobacterial population. A total of 68 strains were used in 
the enrichment step and because the collection dates for the two sample types were different, the 
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same number of strains were not used at each sampling time. It is evident that phages were detected 
more often with certain strains than others, which is not surprising because of known host 
specificity of phages (Szafrański et al., 2017; Zheng et al., 2019). A limitation of this study was 
that different collection dates had a varying number, between 47-59, of F. necrophorum subsp. 
necrophorum strains used. This was because some isolates did not grow on either blood agar or in 
BHI broth. The isolates that did not grow were random for each sampling date. Also, for logistical 
reasons, collections of bovine ruminal fluid and city sewage sample were conducted in different 
seasons.  
The finding that phages were isolated from city sewage samples, in addition to ruminal fluid, 
was not unexpected. Fusobacterium necrophorum is also a member of the normal bacterial flora 
of the human throat, urogenital, and gastrointestinal tracts (Kristensen and Prag, 2000; Amess et 
al., 2007; Kuppalli et al., 2012). In humans, F. necrophorum is an opportunistic pathogen and 
causes pharyngotonsillitis, especially in adolescent and young adults, and in rare situations leads 
to an invasive infection called Lemierre syndrome (Kristensen and Prag, 2000; Amess et al., 2007; 
Eaton and Swindells, 2014; Holm et al., 2017). The strains of F. necrophorum isolated from 
humans are more often subsp. funduliforme than subsp. necrophorum (Tadepalli et al., 2008; Holm 
et al., 2017). A surprising finding in our study was the higher frequency of detection of phages 
from city sewage samples than bovine ruminal fluid. There was approximately a two-fold increase 
in the overall frequency of bacteriophage isolation lytic to F. necrophorum subsp. necrophorum 
from city sewage compared to ruminal fluid samples. 
 Conclusion 
In summary, relative frequencies of bacteriophage isolation lytic to F. necrophorum subsp. 














First spots were made from rumen or sewage fluids on F. necrophorum lawns and bacteriophage 
plaques were observed (a). Then plaques were harvested, diluted, mixed with F. necrophorum 
culture, and spread plated onto blood agar. Single plaques were harvested of the same 
morphologies (b). These filtrates were then spotted onto lawns of F. necrophorum and these large 












Table 3.1. Relative frequency of bacteriophage isolations from bovine ruminal fluid and city 
sewage samples with Fusobacterium necrophorum strains of liver abscess origin. 
a Relative frequency of isolation was higher with city sewage sample compared to ruminal fluid 












No. positive isolated/no. of 
F. necrophorum strains 
Relative frequency, % 
Ruminal fluid 7/29/2019 15/59 25.4 
8/12/2019 9/54 16.7 
8/26/2019 2/53 3.8 
9/9/2019 0/51 0 
10/28/2019 3/47 6.4 
    
City sewagea 10/21/2019 13/52 25.0 
12/2/2019 13/51 25.5 
12/9/2019 7/51 13.7 
12/16/2019 16/50 32.0 




Table 3.2. Frequency of bacteriophage isolations from bovine ruminal fluid and city sewage 
samples with Fusobacterium necrophorum strains of liver abscess origin. 
Bovine ruminal fluid  City sewage 
No. of F. 
necrophorum strains 
Frequency of phage 
isolation 
 




43 0  26 0 
15 1  19 1 
7 2  1 2 
. .  5 3 
. .  2 4 

















Table 3.3. Number of bacteriophages isolated from bovine ruminal fluid or city sewage samples 




















2016-13-12  1/4  25.0  .  . 
2016-13-15  0/5  0  1/5  20.0 
2016-13-17  0/4  0  1/3  33.3 
2016-13-28  1/5  20.0  .  . 
2016-13-58  0/2  0  1/4  25.0 
2016-13-67  0/5  0  1/4  25.0 
2016-13-68  1/4  25.0  0/5  0.0 
2016-13-75  0/5  0  1/5  20.0 
2016-13-77  0/5  0  1/5  20.0 
2016-13-89  1/5  20.0  0/5  0 
2016-13-91  0/5  0  1/5  20.0 
2016-13-92  0/3  0  1/4  25.0 
2016-13-102  1/5  20.0  0/5  0 
2016-13-890  1/4  25.0  0/5  0 
2016-13-8  1/5  20.0  1/5  20.0 
2016-13-10  1/5  20.0  1/5  20.0 
2016-13-14  1/5  20.0  1/3  33.3 
2016-13-36  2/5  40.00  0/5  0 
2016-13-46  2/5  40.0  0/5  0 
2016-13-49  0/5  0  3/5  60.0 
2016-13-62  1/5  20.0  1/4  25.0 
2016-13-66  0/2  0  2/5  40.0 
2016-13-76  1/4  25.0  1/5  20.0 
2016-13-88  2/5  40.0  0/4  0 
2016-13-148  0/5  0  1/5  20.0 
2016-13-9  2/5  40.0  1/5  20.0 
2016-13-10  0/4  0  1/5  20.0 
2016-13-41  0/5  0  3/5  60.0 
2016-13-54  0/5  0  3/5  60.0 
2016-13-57  2/5  40.0  1/3  33.3 
2016-13-61  2/5  40.0  1/5  20.0 
2016-13-63  1/4  25.0  1/5  20.0 
2016-13-83  0/4  0  3/5  60.0 
2016-13-98  2/5  40.0  1/5  20.0 
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2016-13-882  0/1  0  3/5  60.0 
2016-13-51  0/1  0  4/5  80.0 
2016-13-84  .  .  4/5  80.0 
2016-13-11  1/5  20.0  5/5  100.0 
2016-13-29  1/5  20.0  5/5  100.0 
2016-13-69  1/2  50.0  5/5  100.0 





Table 3.4. Number of bacteriophage isolated from bovine ruminal fluid or city sewage samples 
with Fusobacterium necrophorum of liver abscess origin. 
F. necrophorum strains 
No. of bacteriophages isolated 
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Chapter 4 - Characterization of Bacteriophages Lytic to 
Fusobacterium necrophorum of Liver Abscess Origin 
 Abstract 
Fusobacterium necrophorum subsp. necrophorum, an anaerobic ruminal bacterium is the 
primary causative agent of liver abscesses in feedlot cattle. Currently, tylosin, a macrolide, is 
commonly used as a feed additive to reduce the incidence of liver abscesses. Because of the public 
health implication associated with the use of a medically important antimicrobial in food animal 
production system, there is considerable interest in finding an antimicrobial alternative to control 
liver abscesses. Bacteriophages that specifically lyse and reduce population density of F. 
necrophorum subsp. necrophorum in the rumen have the potential to replace tylosin for the control 
of liver abscesses. Our objective was to characterize 25 bacteriophages lytic to F. necrophorum 
subsp. necrophorum previously isolated from rumen fluid and sewage samples. The 
characterization included determination of host specificity, electron microscopic morphology, 
development of insensitivity and optimal pH and temperature stability.  All 25 bacteriophages were 
lytic to F. necrophorum subsp. necrophorum only and did not lyse subsp. funduliforme or any of 
the bacterial species tested. Five bacteriophage morphological classifications belonging to 
Siphoviridae, Myoviridae, Podoviridae, four unclassified with icosahedral heads and no tail, and 
one with multiple tails was unclassified. In broth cultures, 11 bacteriophages inhibited F. 
necrophorum subsp. necrophorum up to 12 hrs, while the other 14 bacteriophages only slightly 
slowed the growth of the bacterium. F. necrophorum subsp. necrophorum became insensitive to 
all 11 lytic bacteriophages after 24 h. At a pH of 2.5, all 11 bacteriophages were inactivated 




exposure and five survived for 1 hr. Between pH 4.5- pH 8.5, no reduction in bacteriophage activity 
was observed. After 24 h of incubation at 30 °C, 40 °C, and 50 °C, all 11 lytic activities 
bacteriophages were unaffected. 
In conclusion, lytic phages were highly host specific, belonged to several morphological 
groups, and their pH and temperature requirements were compatible with ruminal conditions of 
feedlot cattle. However, the development of insensitivity of the susceptible strains could be 
problematic in the application of lytic phages to reduce population density of F. necrophorum 
subsp. necrophorum in the rumen.  
 Introduction 
Fusobacterium necrophorum is the primary causative agent of liver abscesses in cattle 
(Langworth, 1977). The bacterium is an anaerobic, Gram-negative, rod-shaped opportunistic 
pathogen that is a member of the ruminal bacterial flora. Chronic acidosis causes ruminal epithelial 
lesions that facilitate the bacterium to travel to the liver by allowing it to enter the portal blood.  
Two subspecies, necrophorum and funduliforme, are described, which differ in cell and colony 
morphologies, growth patterns and virulence. The subsp. necrophorum is more frequently 
involved in liver abscesses, likely because it is more virulent than the subsp. funduliforme 
(Tadepalli et al., 2009).  
The most recent National Beef Quality Audit Report estimates that liver abscesses cause 58 % 
of all condemned livers in beef cattle processing plants (Eastwood et al., 2017). Therefore, liver 
condemnation are of economic concern for the cattle producers and packers. More importantly, 
liver abscesses cause decreased animal performance and lower carcass yield, which contribute to 
economic loss to the cattle industry, along with increased time and labor costs at the slaughter 




tylosin, a macrolide antibiotic, is used in the feed (Brown et al., 1975; Nagaraja and Lechtenberg, 
2007). Tylosin’s mode of action is to inhibit F. necrophorum and decrease ruminal concentration, 
which decreases the chance of the bacterium to enter the ruminal wall and subsequently reach the 
liver.  Use of in-feed tylosin is of concern because macrolides are medically important antibiotics 
(FDA, 2015). Public health concerns associated with the use of medically important antimicrobials 
causing antimicrobial resistance have led to considerable interests in finding antimicrobial 
alternatives in food animal production systems (Aidara-Kane et al., 2018; Hoelzer et al., 2018).  
 Bacteriophages are viruses that can infect and lyse host bacterial cells (Adams, 1959). They 
have been used for many years as a powerful tool to study bacterial genetics, and because of their 
host specificity, they have been used in the identification and characterization of bacteria, called 
phage typing. Bacteriophages are relatively safe and have no effects on animal or human cells, 
therefore, they have been investigated as potential therapeutic agents against bacterial infections, 
even before the advent of antibiotics (Waldor et al., 2005). Antimicrobial resistance to medically 
important antimicrobials has increased in recent years, which has renewed interest in the use of 
antimicrobial alternatives, including therapeutic use of phages, or phage therapy (Czaplewski et 
al., 2016; Gadde et al., 2017). Food animal meat processing plants have used bacteriophages to 
reduce contaminations of food-borne pathogens (Bruce and James, 2004; Housby and Mann, 2009; 
Tang et al., 2009; Bhardwaj et al., 2015). Eighty-nine bacteriophages from ruminal content and 
city sewage samples lytic to F. necrophorum subsp. necrophorum of liver abscess origin have been 
isolated (Schnur et al., 2021). Here, the characterization of bacteriophages lytic to F. necrophorum 




 Materials and Methods  
 Bacteriophages 
Eighty-nine bacteriophages lytic to F. necropohorum subsp. necrophorum were isolated 
from ruminal fluid and city sewage samples (Schnur et al., 2021). Of these, 29 were isolated from 
ruminal fluid and 60 were isolated from sewage samples. At the time of isolation, bacteriophages 
were frozen at -80 °C in two aliquots of 100 µL mixed with 300 µl 20 % glycerol. For the current 
study, 50 of the frozen bacteriophage stocks were randomly selected, thawed, spotted onto the F. 
necrophorum strain they were originally isolated from, and harvested as previously described by 
Schnur et. al. (2021). The fresh bacteriophage stocks were stored at 4 °C until further analysis was 
performed.  
 F. necrophorum strains  
Thirty strains of F. necrophorum subsp. necrophorum, previously isolated from liver 
abscesses of beef cattle, were used to determine the host range (Amachawadi et al., 2017). The 
strains, stored at -80 °C, were streaked onto sheep blood agar plates (SBA; Remel Inc., Lenexa, 
KS) and incubated for 48 h at 37 °C in an anaerobic glove box (Forma Scientific Inc., Marietta, 
OH). Single colonies were inoculated into 10 ml pre-reduced (with 0.05 % cysteine HCl; Sigma-
Aldrich, St. Louis, MO), anaerobically sterilized brain heart infusion broth (PRAS-BHI; Becton 
Dickinson, Sparks, MD) and incubated at 37 °C overnight. 
 Host specificity 
Bacteriophages were prepared by making a lawn of an overnight culture of F. necrophorum 
on SBA with sterile cotton swabs and 20 µL of the frozen bacteriophage stock (Schnur et al., 
2021).  The plates were placed agar side down in a humidified anaerobic glove box and incubated 




were then harvested by pipetting the agar surrounding the plaque with a transfer pipette into 500 
µL sterile SM buffer (G-Biosciences, St. Louis, MO) in 1.5 mL Eppendorf tubes and allowed to 
elute overnight. The buffer with harvested bacteriophages was centrifuged for 30 seconds at 12,000 
x g to sediment agar pieces. The supernatant was then transferred to a sterile Spin- X tube with a 
0.22 µm membrane filter (Corning Costar, Corning, New York) and centrifuged for 2 minutes at 
12,000 x g. The filtrates were serially diluted 10-fold in SM buffer and each dilution was spotted 
onto a new lawn of the corresponding F. necrophorum strain. Bacterial lawns were checked for 
single plaques, which were then harvested as described above and stored at 4 °C. Next, individual 
bacterial cultures were spread-plated on SBA with sterile cotton swabs to obtain bacterial lawns 
and 20 µL of each bacteriophage were spotted onto each plate with 6 bacteriophages/ SBA. A total 
of 50 bacteriophages were spotted onto 30 strains of F. necrophorum subsp. necrophorum and 20 
bacteriophages were tested against five F. necrophorum subsp. funduliforme strains, four F. 
varium strains, three F. nucleatum strains, one each of strains F. equinum, F. ulcerans, F. 
gonidiaformans, F. russii, F. gastrosuis, six Escherichia coli O157 strains, five strains of 
Campylobacter coli, and four strains of C. jejuni, and one strain each of Salmonella typhimurium, 
Klebsiella pneumoniae, K. oxytoca, Staphylococcus aureus, and Pseudomonas auruginosa. The 
plates were placed agar side down in an aerobic incubator, except for Campylobacter and 
Fusobacterium strains, which were placed in a microaerophilic incubator (5 % oxygen, 10% 
carbon dioxide and 85 % nitrogen) or in an anaerobic glove box, agar side down, respectively, and 
incubated at 37 °C overnight. The following day the plates were examined for phage plaques. The 
number of bacterial strains that each bacteriophage lysed was recorded and the 25 bacteriophages 




 Standardization of bacteriophage stock concentrations   
Bacteriophage stocks were made as described by Bonilla et al. (2016). Ten microliters of 
filtrates from bacteriophages lytic to F. necrophorum were serially diluted ten-fold in 90 µL of 
sterile SM buffer) in a 96-well plate. One hundred microliters of an overnight culture of F. 
necrophorum subsp. necrophorum were then added to each well to mix with dilutions of 
bacteriophage. Two hundred microliters of the F. necrophorum and bacteriophage mixture were 
then spread-plated onto SBA for all the dilutions. The plates were incubated overnight at 37 °C in 
an anaerobic glove box and individual bacteriophage plaques were counted and the plaque forming 
units (PFU/ml) were determined. Each bacteriophage stock was diluted to a concentration of 104 
and the concentration was confirmed by serial dilution and spread plating on SBA as described 
above and stocks were stored at 4 °C.  
 Electron microscopy 
Individual F. necrophorum cultures were spread-plated on SBA with sterile cotton swabs to 
obtain lawns and 20 µL of bacteriophage stock were spotted onto plates with four spots of one 
individual bacteriophage per plate. The plates were placed agar side down in an anaerobic glove 
box and incubated at 37 °C overnight. The next day, a sterile transfer pipet was used to transfer 
bacteriophage plaques to 1.5 mL microcentrifuge tubes with 500 μL sterile double distilled water 
and allowed to elute overnight at room temperature. The eluted bacteriophages were centrifuged 
for 30 seconds at 12,000 x g, the supernatant was transferred to a sterile Spin-X tube with a 0.22 
um filter (Corning Costar, Corning, NY), and was centrifuged for 2 minutes at 12,000 x g. Twenty 
microliters of bacteriophage filtrate were then pipetted onto a piece of parafilm and 20 μL of 
UranyLess EM Stain (Electron Microscopy Sciences, Hatfield, PA) was pipetted next to, but not 




to place a carbon film, dull side down, on the bacteriophage filtrate. After 1 minute, the carbon 
film was removed with fine tip forceps, gently tapped against a tissue paper, and placed, dull side 
down, on the UranyLess EM stain for 1 minute. The carbon film was removed with fine tip forceps, 
gently tapped against a tissue paper, and placed in the carbon film carrier. The carrier was then 
brought to the Kansas State University Microscopy Facility for visualization under a CM 100 
transmission electron microscope (FEI Company, Hillsboro, OR).  
 F. necrophorum inhibition curve by bacteriophages 
One milliliter of overnight F. necrophorum subsp. necrophorum culture was inoculated into 
10 mL of PRAS-BHI and incubated for 1 hour at 37 °C. One mL of standardized bacteriophage 
stock was added to the culture and incubated at 37 °C for 48 h. Culture absorbance was measured 
at 600 nm at 0, 1, 2, 3, 4, 5, 6, 12, 24, and 48 hours of incubation  
 Bacteriophage insensitivity  
Bacteriophage insensitivity was tested by inoculating 1 ml of overnight F. necrophorum 
subsp. necrophorum into 10 mL of PRAS-BHI and incubating for 1 hour at 37 °C. One mL of 
standardized bacteriophage stock was then added to the culture and incubated at 37 °C for 24 h. A 
cotton swab was used to make a lawn of overnight cultures on SBA, 10 μL of corresponding 
standard bacteriophage stock were pipetted onto the lawn in two spots and the plates were 
incubated overnight in an anaerobic glove box at 37 °C. The following day the plates were 
examined for bacteriophage plaques. If there were no plaques, the F. necrophorum culture was 
considered insensitive to the bacteriophage. Each phage was tested in duplicates and the testing 
was replicated three times. Fusobacterium necrophorum strains that had not been inoculated with 




The overnight cultures that were insensitive were tested against all other lytic bacteriophages 
to determine their susceptibilities.  This was done by inoculating 1 ml of overnight F. necrophorum 
subsp. necrophorum into 10 mL of PRAS-BHI and incubating for 1 hour at 37 °C. One mL of 
standardized bacteriophage stock was then added to the culture and incubated at 37 °C for 24 h. A 
cotton swab was used to make a lawn of overnight cultures on SBA, 10 μL of each virulent standard 
bacteriophage stock was pipetted onto a separate lawn in two spots, and the plates were incubated 
overnight in an anaerobic glove box at 37 °C. The following day, plates were examined for 
bacteriophage plaques. If there were no plaques, the F. necrophorum culture was considered 
insensitive to the bacteriophage. Each phage was tested in duplicate and the testing was replicated 
three times. Fusobacterium necrophorum strains that had not been inoculated with phage were 
used as controls. 
 pH tolerance 
Bacteriophage pH tolerance was tested at pH values of 2.5, 3.5, 4.5, 5.5, 6.5, 7.5, and 8.5 and 
for 0 (control), 30 min, 1, 6, and 24 hr for the 11 bacteriophages (Phages ɸ2019-6-16, ɸ2019-6-
25, ɸ2019-6-30, ɸ2019-6-31, ɸ2019-6-32, ɸ2019-6-34, ɸ2019-6-36B, ɸ2019-6-38, ɸ2019-6-40, 
ɸ2019-6-46, ɸ2019-6-47). Briefly, BHI broth was adjusted to the desired pH values with the 
addition of 1 M NaOH or 1 M HCl, then sterilized through a 0.22 μm syringe filter prior to storage. 
Aliquots (450 µl) of the pH-adjusted BHI were transferred into a 0.22 µ Spin-X tube along with 
50 µl of bacteriophage stock that had been previously standardized to a 1 x 10-4 titer.  The Spin-X 
tubes were then centrifuged at 12,000 x g for 2 minutes at room temperature to filter sterilize the 
bacteriophage-BHI solution. At each designated time point, 10 µl aliquots of the pH-adjusted 
bacteriophage solution were “spotted” onto a blood agar plate with a lawn of F. necrophorum 




glovebox before examining for evidence of phage activity. The plaques were scored as ++, +, and 
-, indicating a zone of complete lysis, zone of incomplete lysis, and no lysis, respectively (Figure 
4.1). Bacteriophage pH stability testing, performed in duplicates, was done twice. 
 Temperature tolerance 
Temperature tolerance of 11 bacteriophages was tested at 30 °C, 40 °C, and 50 °C, at time 
points of 1, 24, and 48 hr of temperature exposure. Briefly, 200 µl of bacteriophage stock that had 
been previously standardized to a 1 x 10-4 titer was aliquoted into sterile 1.5 ml Eppendorf 
(Eppendorf, Germany) tubes. For the 30 °C and 40 °C exposure temperatures, the Eppendorf tubes 
were arranged into a tube rack and placed in incubators, while the 50 °C exposure group was 
submerged into a pre-heated water bath for the duration of the study. At the designated sampling 
time points, the bacteriophages were removed and allowed to return to room temperature. Ten 
microliters of phage were then spotted onto a SBA agar plate that had been streaked with an 
overnight culture of F. necrophorum subsp. necrophorum to obtain a bacterial lawn. 
Bacteriophages were immediately placed in incubators/water bath until the next sampling time 
point. Inoculated plates were incubated overnight at 37 °C in an anaerobic glovebox and checked 
for lysis zones the following day. The lytic zone was scored as described above. Temperature 
stability testing was performed in duplicates and replicated twice.  
 Results 
 Host specificity 
Thirty of the bacteriophages lysed less than 10 F. necrophorum subsp. necrophorum strains, 
while 20 bacteriophages lysed over 10 F. necrophorum subsp. necrophorum strains (Table 4.1; 
Figure 4.2). The highest number of F. necrophorum subsp. necrophorum strains lysed by one 




subsp. necrophorum strains showed no lysis against F. necrophorum subsp. funduliforme, F. 
varium strains, F. nucleatum, F. equinum, F. ulcerans, F. gonidiaformans, F. russii, F. gastrosuis, 
E. coli O157 strains, C. coli, C. jejuni, S. typhimurium, K. pneumoniae, K. oxytoca, S. aureus, and 
P. aeruginosa. 
 Electron microscopy and morphological features 
Electron microscopy was performed on 25 bacteriophages. Six morphological types were 
observed, and based on the morphology, phages were assigned to viral families (Figure 4.3). 
Eleven bacteriophages had non-elongated, helical heads with long and thin tails. Theses phages 
were morphologically classified as phages belonging to the Siphoviridae family. Four 
bacteriophages had medium length tails and were classified as part of the Myoviridae family. Of 
the Myoviridae phages, one had an elongated helical head and the other three had non-elongated 
helical heads. Three bacteriophages had non-elongated helical heads with short tails and two had 
round heads with short tails. These bacteriophages were morphologically assigned to the 
Podoviridae family. Four bacteriophages had round heads with no visible tails and were unable to 
be classified at this time. One bacteriophage had an unusual morphology with three long tail fibers 
and a very large, round head and this bacteriophage could not be assigned to any known phage 
families (Table 4.2). 
 F. necrophorum inhibition curve and insensitivity 
Bacteriophage lytic efficiencies were determined for 25 bacteriophages. In broth cultures, 
eleven bacteriophages inhibited F. necrophorum subsp. necrophorum for up to 12 hr (Table 4.3; 
Figure 4.4). The other 14 bacteriophages did not inhibit F. necrophorum subsp. necrophorum at 
any time points, but slightly slowed the growth of the bacterium in broth cultures. At 24 and 48 




hours, F. necrophorum was considered insensitive against the 11 lytic bacteriophages, and to 
confirm insensitivity spot testing was performed. When the bacteriophages were spotted against 
their corresponding insensitive F. necrophorum, strain no lysis spots were detected (Figure 4.5). 
All virulent bacteriophages were spotted against each insensitive bacteriophage culture. After 24 
hours of incubation, there were no spots on any of the insensitive F. necrophorum cultures when 
each of the virulent bacteriophages were spotted on a lawn (Figure 4.6). As a control, the F. 
necrophorum strains not inoculated with phage were spotted against this parent F. necrophorum 
strain and lysis spots were detected for all bacteriophages. 
 Effects of pH and temperature lytic activity of bacteriophages  
At a pH of 2.5, all 11 bacteriophages were inactivated upon initial exposure with no lytic 
activity observed at any of the six sampling time points. Partial bacteriophage inactivation, noted 
as an incomplete zone of lysis on spotted blood agar plates, was immediate (0 hr) at pH 3.5. 
However, a total of five of the tested bacteriophages were able to survive initial exposure, of which 
two were able to survive up to 30 min of exposure and two were viable for up to 1 hr of exposure 
(Table 4.4). All bacteriophages were completely inactivated after 1 hour of exposure to pH 3.5. 
Between pH 4.5- pH 8.5, no reduction in bacteriophage activity was observed, with all 11 
bacteriophages consistently producing complete zones of lysis at 24 hours.  
The same 11 bacteriophages used for pH stability analysis were chosen to determine 
temperature stability over a 48-hour period. None of the bacteriophages showed any loss of 
viability after 48 hours of exposure to any of the three tested temperatures (30, 40 or 50 °C), 





Currently, antimicrobial feed additives are used to control liver abscesses. The most widely 
used antibiotic is a macrolide antibiotic, tylosin (Nagaraja and Chengappa, 1998). Tylosin is a 
narrow spectrum antibiotic that is predominantly effective against Gram-positive bacteria 
(Gingerich et al., 1977). However, the antibiotic inhibits some Gram-negative bacteria, including 
F. necrophorum (Tan et al., 1994; Lechtenberg et al., 1998). Although tylosin is solely used in 
animals, it is similar to erythromycin and antibiotics in the macrolide class are categorized as 
medically important because of their widespread use in human medicine (Scott et al., 2019). 
Therefore, there is a growing public concern about the use of tylosin in animals (FDA, 2021). The 
effect of tylosin use on antimicrobial resistance is of some concern, but studies have shown it has 
little effect on AMR (Nagaraja et al., 1999; Zaheer et al., 2013; Alicia et al., 2015; Amachawadi 
et al., 2017; Müller et al., 2018; Schmidt et al., 2020). Because of the public health concerns 
regarding the use of a medically important antibiotic in cattle diets, there is considerable interest 
in finding alternatives to replace tylosin. 
Phage therapy could be an effective tool against bacterial infections in animal and human 
medicine (Joerger, 2003; Matsuzaki et al., 2005; Kutateladze and Adamia, 2010; Ghosh et al., 
2019; Saha and Mukherjee, 2019). Virulent or lytic bacteriophages are a possible antimicrobial 
alternative to treat animal and human infections (Waldor et al., 2005). However, limited research 
has been conducted on phages lytic to bacterial pathogens in cattle. There has only been one report 
of isolation of bacteriophages lytic to F. necrophorum and the phage, FnP1 was lytic to both 
subspecies of F. necrophorum (Tamada et al., 1985). Interestingly, the 25 bacteriophages 
examined in the current study were only lytic to F. necrophorum subsp. necrophorum and not to 




(Machuca et al., 2010). However, unlike the phages in the current study, Fnpɸ02 was lytic to 
multiple subspecies of F. nucleatum. 
The characterized bacteriophages could be classified into three different phage groups or 
families: groups A, B, and C or the families Myoviridae, Siphovirida, and Podoviridae, 
respectively (Bradley, 1967; Hyman and Abedon, 2012). Of the 25 bacteriophages characterized, 
four were phenotypically part of the Myoviridae family, like the one other characterized 
bacteriophage lytic to F. necrophorum, phage FnP1 (Tamada et al., 1985). Unlike the 25 
bacteriophages characterized, phage FnP1 was lytic to both F. necrophorum subsp. necrophorum 
and fundilforme. Myoviridae bacteriophages have contractile tails and icosahedral heads that can 
be elongated (Hyman and Abedon, 2012). One other fusobacterial Myoviridae bacteriophage has 
been characterized as lytic to Fusobacterium symbiosis (Foglesong and Markovetz, 1974). Eleven 
of the bacteriophages were Siphoviridae family phages. Siphoviridae bacteriophages have long, 
thin, and flexible tails that are not contractile with an icosahedral head (Hyman and Abedon, 2012). 
Hohne et al. (1997) discovered three Siphoviridae fusobacterial phages (fv 8501, fv 2377, and fv 
2527) lytic to Fusobacterium varium from sewage plants. Two other Siphoviridae family 
fusobacterial bacteriophages (FNU1 and Fnpɸ02) have also been isolated from human oral 
samples that were lytic to Fusobacterium nucleatum (Machuca et al., 2010; Kabwe et al., 2019). 
Moreover, five bacteriophages were part of the Podoviridae family, characterized by an 
icosahedral head with a very short tail (Hyman and Abedon, 2012). Four characterized 
fusobacterial bacteriophages (Phage f277, fv 81-531/2, fv 83-554/3, and phage 277) lytic to F. 
varium are also classified as Podoviridae family phages (Bradley, 1967, 1972; Höhne et al., 1997). 
Four bacteriophages were tailless with a round head and could not be classified at this time because 




Abedon, 2012). There has been one other tailless fusoabacterial bacteriophage, ɸFonu2, that is 
lytic to F. nucleatum described, but it has an icosahedral head (Cochrane et al., 2016). One of the 
bacteriophages characterized, ɸ2019-6-20A, had a novel phenotypic morphology. This 
bacteriophage was similar to Siphiloviridae family bacteriophages, as it had long and thin tails. 
However, ɸ2019-6-20A had multiple tails and a round head, which is not seen in the Siphiloviridae 
family (Bradley, 1967; Hyman and Abedon, 2012).  
Eleven bacteriophages inhibited F. necrophorum subsp. necrophorum for up to 24 h. All 11 
bacteriophages showed lysis of bacteria after 1-2 hours after phage inoculation. Bacteriophages 
lytic to F. nucleatum, characterized by Machuca et al. (2010), had much slower bacterial lysis. 
These bacteriophages showed lysis 30 hours after phage inoculation. However, the F. varium 
bacteriophage 277 showed lytic activity around 20 minutes after phage inoculation (Bradley, 
1972). After 24, F. necrophorum subsp. necrophorum became insensitive to all 11 of the 
bacteriophages, which is a major limitation for phage therapy (Tanji et al., 2004; Gu et al., 2012; 
Shlezinger et al., 2017). To overcome insensitivity, phage cocktails can be made with 
bacteriophages that use different bacterial membrane receptors (Tanji et al., 2004). To our 
knowledge, no phage cocktails have been made against Fusobacterium to combat bacteriophage 
insensitivity. However, Tanji et al. (Tanji et al., 2005) made a phage cocktail of three 
bacteriophages for use against E. coli O157:H7 and no insensitivity was observed, whereas 
bacterial insensitivity was seen when each of the bacteriophages were tested against E. coli 
O157:H7 separately. Furthermore, Gu et al. (2012) used a phage cocktail against K. pneumoniae 
to reduce bacteriophage insensitivity. Unfortunately, F. necrophorum subsp. necrophorum became 
insensitive to all 11 bacteriophages after 24 h inoculation with one bacteriophage, indicating that 




Establishing the pH and temperature stabilities of the bacteriophages was important because 
they need to survive physiological environment of the rumen and storage conditions. The pH 
values chosen included a pH range representing the physiological pH fluctuations of the bovine 
rumen. If the rumen pH is below 5.6 for over 3-5 hours then the rumen is likely to be acidotic, 
which lead to lesions that allow F. necrophorum to travel from the rumen to the liver (Nagaraja 
and Chengappa, 1998; AlZahal et al., 2008). The phages became inactive against F. necrophorum 
subsp. necrophorum after 0 h and 0-1 h at pH’s of 2.5 and 3.5, respectively. The bacteriophages 
were not inactivated by pH’s 4.5-8.5, demonstrating their ability to survive in the physiological 
pH of cattle rumens. Moreover, the temperature of the rumen is around 39 °C and storage 
conditions in cattle production systems can be variable depending on location (Rutherford et al., 
2019). Consequently, the activity of 11 bacteriophages was examined after 24 hours of exposure 
to 30 °C, 40 °C, and 50 °C. The bacteriophages were all active after 24 h exposure to each 
temperature.  
 Conclusions 
In conclusion, 25 bacteriophages were characterized and classified into three bacteriophage 
families: Myoviridae, Siphoviridae, and Podoviridae. Five bacteriophages could not be classified. 
One unclassified bacteriophage had multiple, while the other four had no visible tails. The 
bacteriophages were specific to F. necrophorum subsp. necrophorum and 11 were inhibitory to 
the bacterium in broth cultures. However, after 24 hours of incubation, F. necrophorum subsp. 
necrophorum became insensitive to all phages and all of the phages likely use the same bacterial 
membrane receptor to infect the bacterium. Moreover, the bacteriophages were active after 24 






















Figure 4.1. Bacteriophage plaques scored as negative (-) , partial (+) and complete lysis (++) on 




Table 4.1. Host range of bacteriophages with strains of Fusobacterium necrophorum subsp. 
necrophorum of liver abscess origin. 
Under 10 F. necrophorum strains with 
lysis spots 
 Ten or more F. necrophorum strains with 
lysis spots 
Phage ID 




 No. of F. necrophorum 
strains  
ɸ2019-6-1  2  ɸ2019-6-15  12 
ɸ2019-6-2  2  ɸ2019-6-16  16 
ɸ2019-6-3  2  ɸ2019-6-17  14 
ɸ2019-6-4  2  ɸ2019-6-18  11 
ɸ2019-6-5  2  ɸ2019-6-19  13 
ɸ2019-6-6  2  ɸ2019-6-20  15 
ɸ2019-6-7  2  ɸ2019-6-25  12 
ɸ2019-6-8  7  ɸ2019-6-30  10 
ɸ2019-6-9  2  ɸ2019-6-31  14 
ɸ2019-6-10  2  ɸ2019-6-32  17 
ɸ2019-6-11  2  ɸ2019-6-33  13 
ɸ2019-6-12  2  ɸ2019-6-34  16 
ɸ2019-6-13  1  ɸ2019-6-36  14 
ɸ2019-6-14  2  ɸ2019-6-37  12 
ɸ2019-6-21  3  ɸ2019-6-38  16 
ɸ2019-6-22  2  ɸ2019-6-40  15 
ɸ2019-6-23  2  ɸ2019-6-41  16 
ɸ2019-6-24  2  ɸ2019-6-46  17 
ɸ2019-6-26  8  ɸ2019-6-47  18 
ɸ2019-6-27  8  ɸ2019-6-48  14 
ɸ2019-6-28  6  -  - 
ɸ2019-6-29  0  -  - 
ɸ2019-6-35  2  -  - 
ɸ2019-6-39  5  -  - 




ɸ2019-6-43  1  -  - 
ɸ2019-6-44  0  -  - 
ɸ2019-6-45  2  -  - 
ɸ2019-6-49  0  -  - 



























































































































































































































































































































































































































































































A. Phage ID ɸ2019-6-16. Siphoviridae family 
B. Phage ID ɸ2019-6-20A. Unknown family 
C. Phage ID ɸ2019-6-25A. Myoviridae family 
D. Phage ID ɸ2019-6-30. Podoviridae family  
E. Phage ID ɸ2019-6-33A. Myoviridae family  
F. Phage ID ɸ2019-6-15A. Unknown family 
A B C 
D E F 








Head width (nm) 
Head height 
(nm) 
Tail width 1 
(nm) 
Tail length 1 
(nm) 
Tail width 2 
(nm) 
Tail length 2 
(nm) 
Tail width 3 
(nm) 
Tail length 3 
(nm) 
ɸ2019-6-15A Unknown 106.3 119.0       
ɸ2019-6-15B Unknown 93.6 107.5       
ɸ2019-6-16 Siphoviridae 89.1 100.4 12.9 179.0     
ɸ2019-6-18A Podoviridae 95.2 96.7 12.6 47.1     
ɸ2019-6-19A Unknown 132.2 128.2       
ɸ2019-6-19B Podoviridae 74.5 75.1 22.3 28.9     
ɸ2019-6-20A Unknown 139.3 149.4 5.1 249.0 5.5 286.8 3.7 246.3 
ɸ2019-6-20B Unknown 139.6 147.8       
ɸ2019-6-25 Myoviridae 81.0 92.5 23.0/ 3.5a 55.8/ 33.6a     
ɸ2019-6-30 Podoviridae 51.6 53.9 8.4 11.0     
ɸ2019-6-31 Siphoviridae 63.2 74.2 11.0 206.6     
ɸ2019-6-32 Siphoviridae 57.2 55.5 7.2 177.7     
ɸ2019-6-33A Myoviridae 93.1 96.5 27.4/ 8.4a 90.2/ 78.1a     
ɸ2019-6-33B Podoviridae 59.8 56.9 50.1 30.4     
ɸ2019-6-34 Myoviridae 76.9 82.3 19.9/ 6.3a 54.9/ 62/5a     
ɸ2019-6-36A Podoviridae 104.7 106.9 9.0 20.4     
ɸ2019-6-36B Siphoviridae 133.3 140.1 9.6 133.8     
ɸ2019-6-37A Siphoviridae 113.4 121.0 8.1 131.5     
ɸ2019-6-37B Siphoviridae 42.5 55.8 7.8 194.2     
ɸ2019-6-38 Siphoviridae 57.5 61.8 11.1 185.7     
ɸ2019-6-40 Siphoviridae 42.3 47.5 7.4 155.2     
ɸ2019-6-41A Siphoviridae 56.5 57.3 7.7 126.1     
ɸ2019-6-41B Siphoviridae 96.6 96.4 24.8 143.0     
ɸ2019-6-46 Siphoviridae 97.1 90.9 26.8 165.9     
ɸ2019-6-47 Myoviridae 95.7 93.0 27.7/ 7.2a 55.8/ 38.8a     















 Growth (Absorbance at 600 nm) 
 0 1 2 3 4 5 6 12 24 48 
No phage  0.23 0.40 0.60 0.68 0.75 0.78 0.79 0.80 0.80 0.64 
ɸ2019-6-15A  0.15 0.22 0.41 0.53 0.66 0.72 0.73 0.74 0.77 0.64 
ɸ2019-6-15B  0.21 0.33 0.55 0.63 0.69 0.72 0.73 0.74 0.76 0.63 
ɸ2019-6-16  0.16 0.14 0.06 0.05 0.04 0.04 0.04 0.08 0.63 0.64 
ɸ2019-6-18A  0.19 0.32 0.57 0.66 0.70 0.68 0.67 0.69 0.67 0.57 
ɸ2019-6-19A  0.13 0.21 0.39 0.51 0.63 0.70 0.70 0.62 0.74 0.60 
ɸ2019-6-19B  0.13 0.20 0.37 0.48 0.62 0.69 0.71 0.73 0.74 0.60 
ɸ2019-6-20A  0.12 0.18 0.36 0.47 0.61 0.68 0.70 0.72 0.73 0.53 
ɸ2019-6-20B  0.12 0.18 0.36 0.47 0.61 0.71 0.73 0.75 0.76 0.60 
ɸ2019-6-25  0.14 0.18 0.14 0.09 0.06 0.06 0.05 0.15 0.58 0.58 
ɸ2019-6-30  0.23 0.08 0.03 0.03 0.03 0.03 0.04 0.08 0.65 0.64 
ɸ2019-6-31  0.26 0.11 0.06 0.05 0.05 0.04 0.04 0.10 0.61 0.59 
ɸ2019-6-32  0.12 0.15 0.06 0.05 0.04 0.04 0.04 0.08 0.66 0.67 
ɸ2019-6-33A  0.13 0.18 0.36 0.47 0.61 0.67 0.65 0.62 0.67 0.54 
ɸ2019-6-33B  0.19 0.31 0.56 0.64 0.68 0.68 0.68 0.71 0.71 0.56 
ɸ2019-6-34  0.13 0.13 0.05 0.04 0.04 0.04 0.04 0.15 0.64 0.63 
ɸ2019-6-36A  0.13 0.18 0.34 0.44 0.58 0.64 0.62 0.60 0.66 0.54 
ɸ2019-6-36B  0.15 0.10 0.16 0.18 0.07 0.06 0.06 0.19 0.51 0.50 
ɸ2019-6-37A  0.15 0.22 0.40 0.52 0.65 0.72 0.72 0.74 0.76 0.56 
ɸ2019-6-37B  0.22 0.36 0.60 0.69 0.74 0.76 0.77 0.76 0.78 0.61 
ɸ2019-6-38  0.14 0.14 0.05 0.04 0.04 0.04 0.04 0.10 0.62 0.63 
ɸ2019-6-40  0.16 0.15 0.05 0.04 0.05 0.04 0.04 0.14 0.61 0.59 
ɸ2019-6-41A  0.15 0.23 0.40 0.51 0.64 0.71 0.73 0.75 0.76 0.59 
ɸ2019-6-41B  0.15 0.22 0.38 0.47 0.54 0.60 0.60 0.63 0.69 0.59 
ɸ2019-6-46  0.16 0.20 0.07 0.05 0.05 0.04 0.04 0.09 0.58 0.59 
























BHI only F. necrophorum 2016-13-58A only ɸ2019-6-15A ɸ2019-6-15B
ɸ2019-6-16 ɸ2019-6-18A ɸ2019-6-19A ɸ2019-6-19B
ɸ2019-6-20A ɸ2019-6-20B ɸ2019-6-25 ɸ2019-6-30
ɸ2019-6-33A ɸ2019-6-33B ɸ2019-6-34 ɸ2019-6-36A
ɸ2019-6-36B ɸ2019-6-37A ɸ2019-6-37B ɸ2019-6-38
ɸ2019-6-40 ɸ2019-6-41A ɸ2019-6-41B ɸ2019-6-46
ɸ2019-6-47 ɸ2019-6-30 ɸ2019-6-31



























ɸ 2019-6- ɸ 2019-6-
Control ɸ 2019-6-
ɸ 2019-6- ɸ 2019-6-
Insensitive to ɸ 2019-6-34 Insensitive to ɸ 2019-6-16 Insensitive to ɸ 2019-6-47 Insensitive to ɸ 2019-6-46 
Insensitive to ɸ 2019-6-32 Insensitive to ɸ 2019-636B Insensitive to ɸ 2019-6-38 Insensitive to ɸ 2019-6-25 
Insensitive to ɸ 2019-6-31 Insensitive to ɸ 2019-6-30 Insensitive to ɸ 2019-6-40 
Figure 4.5. Fusobacterium necrophorum subsp. necrophorum insensitivity to bacteriophages after 

































Insensitive to ɸ 2019-6-34 
Insensitive to ɸ 2019-6-16 Insensitive to ɸ 2019-6-25 Insensitive to ɸ 2019-6-30 
Insensitive to ɸ 2019-6-31 Insensitive to ɸ 2019-6-32 
Insensitive to ɸ 2019-6-36B Insensitive to ɸ 2019-6-38 Insensitive to ɸ 2019-6-40 
ɸ Insensitive to 2019-6-46 ɸ Insensitive to 2019-6-47 
Figure 4.6. Fusobacterium necrophorum subsp. necrophorum insensitivity to bacteriophages after 




































Hour  Phage ID  2.5  3.5  4.5  5.5  6.5  7.5  8.5 
0 
 ɸ2019-6-16  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-25  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-30  -  -  ++  ++  ++  +  ++ 
 ɸ2019-6-31  -  -  ++  ++  ++  +  ++ 
 ɸ2019-6-32  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-34  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-36B  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-38  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-40  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-46  -  -  ++  ++  ++  ++  + 
 ɸ2019-6-47  -  -  ++  ++  ++  ++  + 
                 
0.5 
 ɸ2019-6-16  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-25  -  +  ++  ++  ++  ++  + 
 ɸ2019-6-30  -  -  +  ++  ++  ++  + 
 ɸ2019-6-31  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-32  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-34  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-36B  -  ++  ++  ++  ++  ++  ++ 
 ɸ2019-6-38  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-40  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-46  -  -  +  ++  ++  ++  + 
 ɸ2019-6-47  -  -  ++  ++  +  +  ++ 
                 
1 
 ɸ2019-6-16  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-25  -  -  +  ++  ++  +  + 
 ɸ2019-6-30  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-31  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-32  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-34  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-36B  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-38  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-40  -  +  ++  ++  ++  ++  ++ 
 ɸ2019-6-46  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-47  -  -  ++  ++  ++  +  ++ 
                 
6 
 ɸ2019-6-16  -  -  ++  ++  ++  ++  ++ 




 ɸ2019-6-30  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-31  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-32  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-34  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-36B  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-38  -  -  ++  ++  ++  +  ++ 
 ɸ2019-6-40  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-46  -  -  ++  ++  ++  ++  + 
 ɸ2019-6-47  -  -  +  +  ++  ++  + 
                 
24 
 ɸ2019-6-16  -  -  ++  ++  ++  ++  + 
 ɸ2019-6-25  -  -  ++  ++  ++  ++  + 
 ɸ2019-6-30  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-31  -  -  +  ++  ++  ++  ++ 
 ɸ2019-6-32  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-34  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-36B  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-38  -  -  ++  +  +  ++  ++ 
 ɸ2019-6-40  -  -  ++  ++  ++  ++  ++ 
 ɸ2019-6-46  -  -  ++  ++  +  +  ++ 
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Chapter 5 - CRISPR-Cas use on disease causing bacterial species in 
cattle 
 Introduction 
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), in conjunction with 
CRISPR-associated (Cas) proteins, have the potential to be used as an antibiotic alternative and 
disease diagnostic tool in animal production. CRISPR-Cas proteins are endonucleases that are 
naturally produced by bacteria and are used as a defense mechanism against foreign nucleic acids, 
such as bacteriophages (Makarova et al., 2006; Brouns et al., 2008; Josiane et al., 2010). In short, 
CRISPR-Cas complexes cleave DNA or RNA and are typically guided by a short RNA strand 
(Elitza et al., 2011; Jinek et al., 2012a). It was first discovered in 1987 by Ishino in E. coli and in 
2002 it started being called CRISPR (Jansen et al., 2002; Ishino et al., 2018). The CRISPR-Cas 
systems contain short non-repetitive sequences (protospacers) between repetitive sequences and 
6-20 Cas protein genetic sequences (Shabbir et al., 2016).  
There are three steps involved in DNA cleavage in bacterial CRISPR-Cas systems (Figure 
5.1): adaptation, expression, and interference (Jackson et al., 2017). Cas1 and Cas2 proteins are 
involved in adaptation and acquisition of protospacers from foreign invaders (Wan et al., 2021). 
Once a bacterium has a protospacer, the genetic sequence is expressed as a guide RNA (gRNA) 
(Jackson et al., 2017). The complex then enters the interference stage, where the gRNA recognizes 



















Additionally, there is a necessary protospacer adjacent motif (PAM) sequence near the 
target nucleic acid sequence that unlocks the cutting mechanisms of the CRISPR-Cas system 
(Mojica et al., 2009; Jinek et al., 2012a; Shah et al., 2013; Doudna and Charpentier, 2014). The 
PAM sequence binding is essential for the cleavage of the target nucleic acid in many CRISPR-
Cas systems (Gasiunas et al., 2012; Jinek et al., 2012a; Sternberg et al., 2014). There are two major 
classes of CRISPR-Cas systems (Table 5.1), Class 1 and 2, and six types of systems within the 
classes, I, II, III, IV, V, and VI (Makarova et al., 2015).  Class 1 systems consist of types I, III, and 
IV, while Class 2 systems consist of types II, V, and VI (Chylinski et al., 2014; Makarova et al., 







Table 5.1. Classification of CRISPR-Cas systems. a 




































I-D Cyanothece spp. 8802 - 
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Table 5.1 continued… 



































Francisella novicida NGG 





















































sp. PCC 8801, Rothia 
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V-G - - RNA 
V-H - - - 
V-I - - DNA 
V-K 







Table 5.1 continued… 

















Leptotrichia shahii PAM not 
required; 

















a (Westra et al., 2013; Chylinski et al., 2014; Makarova and Koonin, 2015; Makarova et al., 2015; Makarova et al., 2017; 
Shmakov et al., 2017; Gleditzsch et al., 2019; Liu and Doudna, 2020; Makarova et al., 2020; Nidhi et al., 2021; Taylor et 
al., 2021) 
 
Class I systems utilize multi-protein effector complexes and are divided into three types, I, 
III, and IV (Makarova et al., 2015). CRISPR-Cas types I and III mostly contain the Cas1 and Cas2 
proteins (Makarova et al., 2017). Type I systems also contain the Cas3 protein and CRISPR arrays. 
The Cas3 protein is a helicase-nuclease and is responsible for DNA cleavage after PAM 
recognition in type I CRISPR-Cas systems (Sinkunas et al., 2011). Types III and IV do not always 
contain CRISPR arrays or adaption module genes (Makarova et al., 2017). Type III types do not 
require a PAM site in the target nucleic acid sequence and are able to cleave both DNA and ssRNA 
(Hale et al., 2009; Deng et al., 2013; Estrella et al., 2016). Furthermore, the Cas10 protein is 
responsible for DNA cleavage, while Cas7 proteins are responsible for ssRNA cleavage in type III 
systems (Samai et al., 2015; Kazlauskiene et al., 2016; Zhang et al., 2016). Type IV systems do 
not contain the Cas 1, Cas2, Cas3, or Cas10 proteins and are associated with Csf4, a DinG family 
nuclease (Liu and Doudna, 2020). Csf4 is necessary for interference in Type IV CRISPR-Cas 




Class II systems utilize a single multidomain effector protein and are divided into three 
types: II, V, and VI. Type II CRISPR-Cas systems are the most studied system and use the Cas9 
nuclease to make a blunt-end DNA double stranded break three base pairs upstream from the PAM 
site (Jinek et al., 2012b; Cong et al., 2013; Mali et al., 2013). Enhanced specificity Cas9 (eCas9) 
and high-fidelity Cas9 (Cas9-HF) are improved spCas9 systems that have less off target effects 
(Kleinstiver et al., 2015; Slaymaker et al., 2016). Furthermore, Type V CRISPR-Cas systems use 
the protein Cas12 to make a staggered DNA double stranded break with a 5’ overhang and Type 
VI systems use Cas13 for promiscuous RNA cleavage (Zetsche et al., 2015; Meeske and 
Marraffini, 2018).  
CRISPR-Cas systems have been modified to create dead Cas proteins (dCas) and Cas9 
nickase (Cas9n) systems. Dead Cas proteins have been modified so they lack nuclease activity but 
are still able to bind to the target nucleic acid sequence (Brezgin et al., 2019). These proteins are 
used to deliver functionally active domains to specific locations in the genome (Brezgin et al., 
2019). These domains may be used for transcriptional regulation, analyzing chromatin structure, 
base editing, epigenetic modeling, and studying chromatin interactions (Komor et al., 2016; 
O'Geen et al., 2017; Zhou et al., 2018; Brezgin et al., 2019). Furthermore, Cas9 has been 
manipulated so it causes single stranded breaks in DNA (Cong et al., 2013; Ran et al., 2013). This 
edited protein is called Cas9 nickase (Cas9n). Cas9n can be used to create more specific double 
stranded breaks with less off target effects than the original Cas9 because it requires the targeting 
of two nucleic acid sites on opposite strands at the same time (Ran et al., 2013).  
 Antimicrobial Alternative Uses of CRISPR-Cas Systems 
Antimicrobial resistance has become a major issue around the world in human and animal 




microbe, can survive in the presence of an antimicrobial. This typically occurs through genetic 
modification of the bacteria so the bacteria can produce proteins to neutralize the antimicrobials, 
increase efflux pumps so antimicrobials are forced out of the microbe, or change the target 
structures so antimicrobials can no longer attach (Gallo, 2013; Gualerzi, 2013). The use of 
antimicrobials can select antimicrobial resistant pathogens and commensal bacteria that can serve 
as vectors that can transfer resistance genes to other pathogenic microbes (Holmes et al., 2016). 
An increase in resistance to medically important antimicrobials, such as macrolides, 
cephalosporins, and glycopeptides has led to public health concerns (Torio and Padilla, 2018; 
WHO, 2019). 
Antimicrobial use of CRISPR-Cas has been studied on few cattle pathogens. However, its 
antimicrobial alternative potential has been demonstrated on Stapylococcus aureus, Clostridium 
difficile, Eschericia coli, Salmonella enterica and Mycobacterium tuberculosis (Bikard et al., 
2014; Gomaa et al., 2014; Kiga et al., 2019; Li et al., 2019; Hao et al., 2020; Selle et al., 2020a). 
For example, Gomaa et. al. (Gomaa et al., 2014) used the endogenous type I-E CRISPR-Cas 
system in E. coli to selectively inhibit bacterial strains in mixed cultures. Bacteriophages and 
bacteria carrying plasmids transmissible by conjugation have been demonstrated to deliver 
CRISPR-Cas9 to E. coli which reduced antimicrobial resistance genes or inhibited growth of the 
bacterium (Citorik et al., 2014). Moreover, bacteriophage-delivered CRISPR-Cas13a inhibited E. 
coli and S. aureus by targeting chromosomal or plasmid DNA through its promiscuous ssRNA 
cleavage (Kiga et al., 2019). CRISPR-Cas9 has also been reported to destroy plasmids carrying 
Beta-lactamase resistance genes in E. coli (Yosef et al., 2015). Bikard et al. (2014) demonstrated 
the use of CRISPR-Cas9 in a mouse skin colonization model to kill S. aureus. Likewise, CRISPR-




efficient at editing the mecA gene and inhibiting bacterial growth (Kang et al., 2017). Selle et al. 
(Selle et al., 2020b, a) demonstrated that bacteriophages engineered with CRISPR-Cas type I 
systems inhibited C. difficile in vitro and in a mouse model. Salmonella enterica has been inhibited 
by CRISPR-Cas9 (Hamilton et al., 2019). Carbapenem-resistant plasmids in K. pneumonia have 
also been cleaved by CRISPR-Cas9 (Hao et al., 2020). Furthermore, bacteriophages have been 
modified to insert gRNAs that interact with M. tuberculosis’ endogenous CRISPR-Cas type III 
system to inhibit the bacterium (Carrigy et al., 2017; Li et al., 2019; Li and Peng, 2019). 
Interestingly, cattle have been modified with CRISPR-Cas9 to cause a genetic mutation that makes 
the cattle more resistant to M. tuberculosis (Gao et al., 2017).  
There are many documented patents for CRISPR-Cas use with common bacterial 
pathogens in cattle and, specifically, as an antimicrobial alternative on cattle pathogens (Table 
5.2). For example, the patent “Altering microbial populations and modifying microbiota” (patent 
number 10,624,349) uses CRISPR-Cas systems to alter S. aureus, P. aeruginosa, C. difficile, E. 
coli, M. tuberculosis, S. pyogenes, S. agalactiae, and more bacterial species in mixed cultures with 
a goal of altering antimicrobial resistant strains so they are inhibited or no longer resistant (Clube, 
2020). Likewise, the patent “Sequence specific antimicrobials” (patent number 10,660,943) uses 
CRISPR-Cas9 to reduce antimicrobial resistant and virulent strains of S. aureus in mixed cultures 
consisting of Staphylococcus, Clostridium, Bacillus, Salmonella, Helicobacter pylori, Neisseria 
gonorrhoeae, Neisseria meningitidis, and Escherichia coli (Bikard and Marraffini, 2020). These 
examples demonstrate the antimicrobial therapies involving CRISPR-Cas being developed and 
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Delivery of CRISPR-Cas systems to bacterial cells in mammalian systems has been a 
challenge, but bacteriophages and nanoparticles have become promising delivery methods. 
Nanoparticles are microscopic particles with varying properties that make them beneficial for 
therapeutic use in the health industry (Anu Mary Ealia and Saravanakumar, 2017). Lipid and 




treating cancer and genetic disorders (Chen et al., 2017; Lee et al., 2018). Likewise, Kang et al. 
(2017) used nanocomplexes to deliver CRISPR-Cas to bacterial cells.  The second delivery method 
is the use of bacteriophages, which are bacterial viruses that insert DNA into a bacterial host. 
Bacteriophages have two possible life cycles: lytic or lysogenic (Snyder, 2013). Lytic 
bacteriophages lyse bacterial cells, while lysogenic bacteriophages insert their DNA into the 
genome of bacterial cells (Snyder, 2013). Lysogenic bacteriophages have been used to insert 
CRISPR-Cas9 into Escherichia coli and Staphylococcus aureus in vitro (Bikard et al., 2014; 
Citorik et al., 2014; Yosef et al., 2015). Some differences between the two methods of delivery are 
that nanoparticles do not have target specificity unless a modality is added to make them specific 
and they can be easily modified, while most bacteriophages have species-specific specificity and 
bacterial resistance can quickly form (Merril et al., 2003; Gómez et al., 2015; Lino et al., 2018). 
Due to the specificity of CRISPR-Cas systems, delivery to more than the target bacteria should 
not cause other, possibly beneficial bacteria to be affected (Jinek et al., 2012a; Cong et al., 2013).  
 CRISPR-Cas Systems to Diagnose Cattle Diseases 
Field deployable, quick, and reliable diagnostic tools are necessary for fast disease treatment 
in cattle production systems. Many CRISPR-Cas system diagnostic tools have been developed that 
fit these needs. For example, finding low abundance sequences by hybridization next generation 
sequencing (FLASH- NGS) is a CRISPR-Cas9 diagnostic tool that cleaves target DNA sequences 
into fragments properly sized for Illumina sequencing (Quan et al., 2019). Quan et al. (Quan et al., 
2019) demonstrated that FLASH-NGS detected antimicrobial resistance genes in respiratory fluid 
and blood. Additionally, DETECTR, DNA endonuclease-targeted CRISPR trans reporter, has 
been demonstrated to have attomolar sensitivity for DNA detection of human papilloma virus and 




sensitivity enzymatic reporter unlocking (SHERLOCK) uses CRISPR-Cas13’s promiscuous RNA 
cleavage activity to detect target DNA sequences (Abudayyeh et al., 2016; East-Seletsky et al., 
2016; Gootenberg et al., 2017). SHERLOCK has been used in conjunction with HUDSON, heating 
unextracted diagnostic nucleases to obliterate nucleases, to detect attomolar levels of Zika and 
Dengue viruses in saliva, urine, and blood serum samples in less than 2 hours (Myhrvold et al., 
2018). Furthermore, STOP, SHERLOCK One-Pot Testing, was designed to detect SARS-CoV-2 
(Segel et al., 2020). In 2018, Gootenberg et al. (2018) designed SHERLOCKv2, which uses Cas13 
and Csm6, an auxillary CRISPR-Cas associated enzyme, to improve SHERLOCK so that it could 
detect multiple target DNA sequences in inputs as low as two attomolar and increase signal 
sensitivity. SHERLOCKv2 can detect more than one target DNA sequence though multiplexing 
and been demonstrated to have high sensitivity to Zika and Dengue viruses (Gootenberg et al., 
2018). Moreover, Lu et al. (2019) designed a LwCas13a nanomachine to detect avain influenza A 
H7N1. In conjunction with reverse-transcription recombinase polymerase amplification assay 
(RT-RPA) and a T7 transcription system, this LwCas13a nanomachine was able to detect 1 fM of 
avian influenza A H7N1 within 50 minutes on a fluorescence plate reader (Liu et al., 2019). 
Moreover, Cas13a has been used to design a mobile phone-based fluorescence microscope that 
has no pre-amplification steps and can detect around 100 copies/ µL of target sequences from 
patient nasal swabs within 30 minutes of measurement time (Fozouni et al., 2021). Likewise, 
magnetic bead-quantum dots (MB-Qdots) have been used in conjunction with CRISPR-Cas12a to 
design a diagnostic tool that can be used with the human eye (Bao et al., 2020). Bao et al. (Bao et 
al., 2020) demonstrated the use of this MB-Qdot CRISPR assay on African swine fever and were 




These different illustrations show how many CRISPR-Cas systems could be applied as rapid and 
reliable diagnostic tools for use in in field diagnosis of cattle diseases.  
 Conclusions and Future Directions 
CRISPR-Cas systems have the potential to diagnose bacterial pathogens and replace 
antibiotics to prevent, control, and treat bacterial infections in cattle production. CRISPR-Cas 
proteins occur naturally in bacteria to precisely cut DNA of invading viruses and disable the virus 
so it does not harm the bacteria similar to a human immune system.  The purpose of this literature 
review was to find literature that used CRISPR-Cas systems to find and alter or detect DNA of 
cattle bacterial pathogens. The CRISPR-Cas complex scans bacterial DNA looking for a match to 
the gRNA within the CRISPR-Cas complex. Once the DNA match is found, a PAM sequence acts 
as a key that unlocks a door which allows the CRISPR-Cas complex editing access to the bacterial 
DNA within the pathogenic bacteria. Once the door is unlocked, the CRISPR-Cas acts as a 
molecular scalpel that cuts the bacterial DNA, which disables the bacteria from normal function, 
causes death of the bacteria, or can lead to detection of a bacterial species. The gRNA identifies 
the bacterial DNA, the PAM unlocks the door and the CRISPR-Cas surgically alters the bacterial 
DNA. The simplicity of CRISPR-Cas has made it easy to modify and cut DNA of many bacterial 
species. Due to the simplicity of modifying CRISPR-Cas systems it is capable of becoming a fast 
and reliable diagnostic tool or an antimicrobial alternative in cattle production. Studies need to be 
conducted on many cattle pathogens to determine if they have an endogenous CRISPR-Cas 
system, how well CRISPR-Cas systems work on the bacterium of interest, and how to effectively 
and safely deliver the CRISPR-Cas systems in cattle. If a bacterium has an endogenous CRISPR-
Cas system, further studies should be conducted to determine the PAM(s) of that system and how 
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Chapter 6 - Preliminary data on CRISPR-Cas9 use as an 
antimicrobial alternative: A novel strategy to inhibit ruminal 
Fusobacterium necrophorum to prevent liver abscesses in feedlot 
cattle 
 Abstract 
Liver abscesses are a major economic concern for cattle producers. The primary causative 
agent of liver abscesses is Fusobacterium necrophorum subsp. necrophorum, an anaerobic ruminal 
bacterium. Currently, tylosin, a macrolide antimicrobial, is regularly used to reduce the incidence 
of liver abscesses in feedlot cattle. Because of the public health concerns associated with the use 
of medically important antimicrobials in cattle used for food production, there is interest in finding 
an antimicrobial alternative to control liver abscesses. Clustered regularly interspaced short 
palindromic repeats (CRISPR) in conjunction with CRISPR-associated proteins are bacterial 
immune mechanisms that can be programmed to inhibit bacteria. Our main objectives were to 
determine if Cas9 with gRNAs could target the genes rpsP and fomA in E. coli and F. 
necrophorum, respectively.  
A 1.3- to 3.3-log10 reduction was observed when the rpsP gene was targeted from a plasmid 
in E. coli. Likewise, when the fomA gene was targeted in F. necrophorum, there was a 1.0- to 3.6-
log10 reduction in bacterial cell counts. However, the Cas9 control reduced bacterial cell counts by 
a 2.0-log10 in F. necrophorum, but not in E. coli. A possible reason for this is that F. necrophorum’s 
endogenous CRISPR-Cas type I system could be producing a gRNA compatible with Cas9. More 




could be used to inhibit F. necrophorum in the rumen or liver as a strategy to reduce the incidence 
of liver abscesses in cattle. 
 Introduction 
Fusobacterium necrophorum is an anaerobic, Gram-negative, rod-shaped bacterial 
opportunistic pathogen that causes liver abscesses in cattle (Langworth, 1977). The bacterium is a 
member of the ruminal bacterial flora, which travels from the rumen to the liver through portal 
circulation to set up abscesses. The pathogenesis includes rumenitis induced by chronic ruminal 
acidity that permits F. necrophorum to penetrate the ruminal wall to cause microabscesses. From 
these abscesses, the organisms enter portal blood to reach the liver. The organism is also a 
causative agent of foot rot and abscesses, and calf diphtheria in cattle (Tan et al., 1996). The species 
of F. necrophorum is classified into two subspecies, necrophorum and funduliforme, which differ 
in cell and colony morphologies, growth pattern in broth, and more importantly, in virulence.  The 
subsp. necrophorum is more virulent, hence, more frequently involved in liver abscesses 
(Tadepalli et al., 2009). The major virulence factor that allows F. necrophorum to evade the 
defense mechanisms of the ruminal wall and liver is leukotoxin, a secreted protein that is cytotoxic 
to leukocytes and macrophages (Nagaraja et al., 2005). The leukotoxin is encoded by a three-gene 
operon, lktABC, of which the second gene, lktA, encodes the leukotoxin protein of 3,241 amino 
acids, with a molecular weight of 335,956 Da (Narayanan et al., 2002). The importance of 
leukotoxin as a virulence factor in F. necrophorum is indicated by a correlation between toxin 
production and the ability to induce abscesses in laboratory animals, an inability of non-
leukotoxin-producing strains to induce foot abscesses in cattle following intradermal inoculation, 
and a relationship between antileukotoxin antibody titers and protection against infection in 




FomA, and a 30S ribosomal protein S16, RpsP, of F. necrophorum subsp. necrophorum are 
encoded by a likely nonessential and an essential gene, respectively (Menon, 2014; Kumar et al., 
2015). FomA has been shown to be a porin protein in F. nucleatum that also aids in bacterial 
adhesion (Liu et al., 2010). In F. necrophorum, Kumar et al. (2015) demonstrated high binding 
affinity to cattle endothelial cells. The DNA sequence of the F. necrophorum’s rpsP gene has been 
shown to be specific to F. necrophorum with > 98 % and > 99 % identity between subsp. 
fundiliforme and necrophorum, respectively. The next closest species is Leptotrichia, with around 
80 % identity.  
The majority of liver condemnations in beef processing plants are due to liver abscesses 
(Reinhardt and Hubbert, 2015; Amachawadi and Nagaraja, 2016). The National Beef Quality 
Audit in 2016 reported 30.8 % liver condemnation compared to the 20.9 % liver condemnation 
rate in 2011. Around 60 % of the condemned livers were due to liver abscesses (Eastwood et al., 
2017). In addition to the loss of liver, the economic impact of liver abscesses to the cattle industry 
includes decreased animal performance and lower carcass yield, as well as time and labor costs at 
cattle processing plants (Nagaraja and Lechtenberg, 2007). Currently, the most common antibiotic 
used to reduce the incidence of liver abscesses is tylosin (Nagaraja and Lechtenberg, 2007; Alicia 
et al., 2015; Müller et al., 2018). The mode of action of tylosin is to inhibit F. necrophorum and 
reduce ruminal concentration, which reduces the opportunity of the bacterium to enter the ruminal 
wall and reach the liver. There is concern with the tylosin use because the antibiotic belongs to the 
macrolide class, which is a medically important antibiotic class (Alicia et al., 2015; FDA, 2015; 
Müller et al., 2018). Antimicrobial resistance to medically important antibiotics has caused a shift 
in antibiotic stewardship, leading to the use of fewer antibiotics in food animal production (Sáenz 




et al., 2019). Finding alternatives to these antibiotics are essential for the health, wellness, and 
productivity of food animals.  
A possible alternative to antimicrobials is clustered regularly interspaced short palindromic 
repeats (CRISPR), along with CRISPR-associated (Cas) proteins. CRISPR-Cas systems are 
bacterial immunity mechanisms against foreign nucleic acids, including bacteriophages 
(Makarova et al., 2006; Brouns et al., 2008; Josiane et al., 2010). There are many different 
CRISPR-Cas proteins, but CRISPR-Cas9 is the most well studied. CRISPR-Cas9 is a class II 
CRISPR-Cas endonuclease that is guided by RNA and cleaves double stranded DNA (Deltcheva 
et al., 2011; Jinek et al., 2012). Cleavage is caused by complementary base pairing of the target 
DNA with a programmable single guide RNA (sgRNA) followed by a necessary protospacer 
adjacent motif (PAM) sequence in the target DNA (Jinek et al., 2012; Shah et al., 2013; Doudna 
and Charpentier, 2014). The binding of the PAM sequence after complementary base pairing of 
the target DNA is necessary for the double stranded cleavage of the target DNA (Gasiunas et al., 
2012; Jinek et al., 2012; Sternberg et al., 2014). Furthermore, CRISPR-Cas9 has been used to edit 
bacterial genomes; therefore, CRISPR-Cas9 paired with an efficient delivery method will 
potentially be able to replace antibiotics (Jiang et al., 2013; Citorik et al., 2014; Gomaa et al., 2014; 
Moreb et al., 2017). For example, bacteriophages have been used to deliver CRISPR-Cas9 to 
Escherichia coli, where the nuclease was able to reduce the presence of antimicrobial resistance 
genes and inhibit bacterial growth (Citorik et al., 2014). Furthermore, CRISPR-Cas9 has also been 
delivered into methicillin- resistant Staphylococcus aureus through nanocomplexes and was 
demonstrated to be efficient at editing and inhibiting the growth of the bacterium (Kang et al., 
2017). Bikard et al. (2014) demonstrated the inhibition of S. aureus with the use of CRISPR-Cas9 




plasmids in E. coli and Klebsiella pneumonia (Yosef et al., 2015; Hao et al., 2020). Because of 
CRISPR- Cas9’s ability to efficiently cleave targeted DNA strands, the protein complex has the 
potential to effectively cleave and disrupt a gene in targeted bacteria. 
Our objective was to demonstrate the use of a CRISPR-Cas9 system to inhibit F. 
necrophorum. This is a novel concept to potentially eliminate or reduce F. necrophorum in the 
rumen and a hypothetical strategy to reduce liver abscesses in cattle. 
 Materials and Methods 
 Plasmid construction 
  A plasmid with the F. necrophorum rpsP gene was designed with the kanR and 
lacZ genes (GenScript, Nanjing, China). The sequence was chosen from the complete genome of 
the F. necrophorum subsp. necrophorum ATCC 25286 (Genebank accession number 
CP034842.1). The inserted sequence size was 286 base pairs. 
 Insertion of F. necrophorum rpsP gene 
New England Biolabs (NEB) 10-beta electrocompetent E. coli (New England Biolabs, 
Ipswich, MA) was placed on ice to thaw. After thawing, 25 µl of the electrocompetent E. coli was 
transferred to a chilled 1.5 mL microcentrifuge tube (Eppendorf, Hamburg, Germany) and 100 ng 
(0.1 µL ) of the plasmid with the F. necrophorum rpsP gene  or the pUC19 plasmid (control; New 
England Biolabs, Ipswich, MA) was gently mixed with the electrocompetent E. coli on ice. The 
mixture was then transferred to a 0.1 cm gap cuvette (Bio-Rad, Hercules, CA) and electroporated 
with a Gene Pulser Xcell Microbial System (Bio-Rad, Hercules, CA) set to 2 kV, 25 µF, and 200 
Ω. Nine hundred and seventy-five microliters of pre-warmed NEB 10-beta outgrowth medium 
(New England Biolabs, Ipswich, MA) were immediately added to the cuvette and pipetted quickly 




and placed in a shaking incubator at 37 °C. After 1 hr of incubation, 100 µL of the electroporated 
cells were serially diluted and each dilution was spread plated onto pre-warmed selective Lennox 
L. (LL) agar (Invitrogen, Waltham, MA) plates with x-gal (Promega, Madison, WI) and either 
kanamycin (MilliporeSigma, Burlington, VT) or ampicillin (MilliporeSigma, Burlington, VT). 
The cells were also streaked for purity on the previously described selection plates. All plates were 
placed in a 37° C incubator overnight. The following day, the plates were examined and PCR was 
used to confirm the insertion of the plasmid with the F. necrophorum rpsP gene from blue colonies 
on kanamycin plates. After confirmation, colonies were saved at -80 °C in Cyrobank freezer beads 
(COPAN Diagnostics, Murrieta, CA). PCR was also used to confirm pUC19 insertion from blue 
colonies on ampicillin plates. 
 PCR assays for rpsP and fomA genes 
 rpsP gene 
Escherichia coli rpsPFI colonies were suspended in 50 µL sterile water, boiled for 10 min, 
and centrifuged for 2 min at 2,200 x g. On ice, 5 µL of 10x buffer, dNTP mix, forward and reverse 
primers (Table 6.1), 3 µL of Mg2+, and 25 µL water were gently combined. Then, 1 µL of the 
boiled and centrifuged E. coli rpsPFI  cells were added and, lastly, 1 µL KOD DNA polymerase 
(New England Biolabs, Ipswich, MA) was added. The mixture was centrifuged for 5 seconds at 
5,000 x g and then a Mastercycler nexus GSX1 (Eppendorf, Hamburg, Germany) was used to run 
the PCR reaction in the sequence of 95 °C for 2 minutes 15 seconds, 54 °C for 30 seconds, 72 °C 
for 40 seconds for a total of 30 times, then the sequence went to 72 °C for 10 minutes before 
finishing. The samples were then placed in a QiAxel Advanced (Qiagen, Hilden, Germany) and 
outputs were analyzed.  




F. necrophorum subsp. necrophorum colonies were suspended in 50 µL sterile water, 
boiled for 10 min, and centrifuged for 2 min at 2,200 x g. On ice, 25 µL GoTaq green master mix 
(Promega, Madison, WI), 2.5 µL forward and reverse primers (Table 6.1), 2.5 µL DNA template, 
and 17.5 µL nuclease free water were gently combined. Then, 1 µL of the boiled and centrifuged 
F. necrophorum subsp. necrophorum cells were added and, then 1 µL KOD DNA polymerase. 
The mixture was centrifuged for 5 seconds at 5,000 x g and then Mastercycler nexus GSX1 
(Eppendorf, Hamburg, Germany) was used to run the PCR reaction in the sequence of 96° C for 3 
minutes 15 seconds, 60 °C for 15 seconds, 54 °C for 15 seconds, 72 °C for 1 minute, repeated for 
a total of 34 times, then the sequence went to 72 °C for 5 minutes. The samples were then placed 
in a QiAxel Advanced (Qiagen) and outputs were analyzed.  
 Bacterial strains 
 E. coli rpsPFI  
Escherichia coli rpsPFI was streaked onto LL agar with kanamycin and X-gal and 
incubated overnight at 37° C. Single blue colonies were inoculated into 10 mL LL broth and placed 
in a 37° C incubator overnight. The following day, 1 mL of overnight culture was pipetted into 10 
mL LL broth and incubated until an OD600 of 0.4- 0.6 (around 2 hours). 
 F. necrophorum subsp. necrophorum 
Fusobacterium necrophorum subsp. necrophorum strain 8L1, stored at -80° C, was 
streaked onto sheep blood agar plates (SBA; Remel Inc., Lenexa, KS) and incubated at 37 °C for 
48 h in an anaerobic glove box (Forma Scientific Inc., Marietta, OH). Single colonies were 
inoculated into 10 ml pre-reduced (with 0.05 % cysteine HCl; Sigma-Aldrich, St. Louis, MO), 




and incubated overnight at 37 °C. The following day, 1 mL of overnight culture was pipetted into 
10 mL PRAS-BHI broth and incubated until an OD600 of 0.4- 0.6 (around 4 hours). 
 Insertion of Cas9 protein and gRNA complex 
 Escherichia coli rpsPFI  
One milliliter of E. coli rpsPFI culture, at an OD600 of 0.4-0.6, was pipetted into a pre-
chilled 1.5 microcentrifuge tube kept on ice and centrifuged at 4 °C for five minutes at 7,000 x g. 
The supernatant was discarded, and the pellet was resuspended in 1 mL, sterile, ice-cold water and 
centrifuged at 4° C for five minutes at 7,000 x g. This was repeated for a total of three washes. 
Then, the pellet was resuspended with 20 µL ice water. Four microliters of the Cas9 protein 
(MilliporeSigma, Burlington, VT) at a concentration of 10 pmol/ µL was gently mixed with 12 µL 
gRNA at a concentration of 30 pmol/ µL and given fifteen minutes to combine at room temperature 
before being placed on ice. Two gRNAs that were designed to target the F. necrophorum rpsP 
gene insert were used independently and mixed (Table 6.2). When the gRNAs were mixed, each 
was allowed to combine separately, with 2 µL Cas9 and 6 µL gRNA, before being mixed together. 
Then, 12 µL reconstitution buffer (MilliporeSigma, Burlington, VT) and 20 µL electrocompetent 
E.coli rpsPFI was added to the Cas9-gRNA combination and gently mixed. The final volume was 
48 µL and this was gently pipetted into a 0.1 cm gap cuvette and electroporated with a Gene Pulser 
Xcell Microbial System set to 2 kV, 25 µF, and 200 Ω. Immediately following electroporation, 
952 µL of stable outgrowth medium (New England Biolabs, Ipswich, MA) was added to a cuvette 
and pipetted quickly and gently. The mixture was then serially diluted in stable outgrowth medium 
and 100 µL of each dilution was spread plated onto LL agar plates with x-gal only and LL agar 
plates with x-gal and kanamycin. The plates were incubated overnight at 37 °C, then colony counts 




coli rpsPFI with individual gRNAs only, and E. coli rpsPFI with Cas9 only. Reconstitution buffer 
was used to bring the controls to a final volume of 48 µL.  
 F. necrophorum subsp. necrophorum 8L1 
One mL of F. necrophorum subsp. necrophorum culture at an OD600 of 0.4-0.6 was 
pipetted into a pre-chilled 1.5 microcentrifuge tube on ice and made electrocompetent as described 
previously. Two gRNAs that were designed to target the fomA gene insert were used independently 
and combined (Table 6.2). When the gRNAs were combined, each was allowed to bind separately, 
with 2 µL Cas9 and 6 uL gRNA, before being mixed together. Then, 12 µL reconstitution buffer 
and 20 µL electrocompetent F. necrophorum subsp. necrophorum was added to the Cas9-gRNA 
combination and gently mixed. The final volume was 48 µL and this was gently pipetted into a 0.1 
cm gap cuvette and electroporated with a Gene Pulser Xcell Microbial System set to 2 kV, 25 µF, 
and 200 Ω. Immediately following electroporation, 952 µL of PRAS-BHI broth was added to a 
cuvette and pipetted quickly and gently. The mixture was then pipetted to a 1.5 mL centrifuge tube 
and placed in an anaerobic glove box, where it was serially diluted in PRAS-BHI broth. One 
hundred microliters of each dilution were spread plated onto SBA plates and incubated overnight 
at 37 °C. Colony counts were recorded, and colonies were picked for PCR. The controls used were 
F. necrophorum subsp. necrophorum only, F. necrophorum subsp. necrophorum with individual 
gRNAs only, and F. necrophorum subsp. necrophorum with Cas9 only. Reconstitution buffer was 
used to bring the controls to a final volume of 48 µL.  
 Statistical analysis 
The cleavage and inhibitory activity of Cas9/gRNA complexes were evaluated using a PROC 
GLM procedure in SAS (Version Studio, Cary, NC). The statistical model included the treatments, 




within and between treatment groups were tested using Student-Newman-Keuls Test with an alpha 
of ≤ 0.05.  
 Results 
 F. necrophorum rpsP gene targeting in E. coli rpsPFI with CRISPR-Cas9 
On LL agar with x-gal and kanamycin a 1.3- to 3.3-log10 reduction was seen in bacterial 
cell counts depending on gRNA(s) used, compared to controls (p-value < 0.0001; Figure 6.1; Table 
6.3). Very few white colonies were observed on LL agar with x-gal and these colonies were 
presumed to have lost the plasmid containing the F. necroophorum rpsP gene which was 
confirmed by PCR (Figure 6.2). Fewer white colonies with a blue center were observed on LL 
agar with x-gal when Cas9 and gRNA2 were tested and some were observed when the gRNAs 
were combined. A slight band for the F. necrophorum rpsP gene was observed in the PCR assay 
of these colonies. 
 CRISPR-Cas9 inhibition of F. necrophorum subsp. necrophorum 8L1 
On SBA agar a 1.0- to 3.6-log10 reduction was seen in bacterial cell counts after 48 h 
incubation in an anaerobic glove box, compared to controls (p-value < 0.0001; Figure 6.3; Table 
6.4). When gRNAs were used with Cas9 independently, there was a 1- to 3.6- log10 decrease; 
however, when used together there was a 1.5- to 3.5-log10 decrease. When comparing only F. 
necrophorum with F. necrophorum + Cas9 + gRNA 1, F. necrophorum + Cas9 + gRNA 2, and F. 
necrophorum + Cas9 + gRNA 1 and 2 combined the log10 differences were 3.6 (p-value = 0.0003), 
3.0 (p-value = 0.0034), and 3.5 (p-value = 0.0005), respectively (Figure 6.4). Interestingly, a 2-
log10 decrease in bacterial cell counts was observed when Cas9 was tested without a gRNA and a 
0.9- to 1.1-log10 decrease was observed when individual gRNAs 1 and 2, respectively, were tested 




0.0229, 0.5987, and 0.2677, respectively). Nonetheless, no statistical differences were seen 
between F. necrophorum + Cas9 control and F. necrophorum + Cas9 + gRNA 1, 2, and combined 
(p-value = 0.3637, 0.2193, 0.2495, respectively; Figure 6.5).  
 Discussion 
Currently, liver abscesses are controlled with antimicrobial feed additives. To control liver 
abscesses the FDA has approved several antimicrobial compounds for use in cattle feed (Feed 
Additive Compendium, 2021). Tylosin, which belongs to the macrolide antimicrobial class, is the 
most commonly used to prevent liver abscesses (Nagaraja and Chengappa, 1998). Tylosin is a 
mainly effective against Gram-positive bacteria, but is also affective against F. necrophorum, a 
Gram-negative bacteria (Gingerich et al., 1977; Tan et al., 1994; Lechtenberg et al., 1998). 
Although tylosin is only used in animals, it is a macrolide similar to erythromycin, and macrolide 
antimicrobials are considered medically important because they are commonly used in human 
medicine (Scott et al., 2019). Therefore, tylosin was placed under veterinary oversight due to a 
growing public health concern of the use of the antimicrobial in animals (FDA, 2021). There is 
some concern with the use of tylosin related to antimicrobial resistance within bacteria found in 
the digestive tract (Zaheer et al., 2013; Alicia et al., 2015; Müller et al., 2018). However, in tylosin-
fed cattle there is no indication of macrolide resistance in F. necrophorum isolated from liver 
abscesses and studies have found minimal AMR impact of tylosin use on gut bacteria (Nagaraja 
et al., 1999; Amachawadi et al., 2017; Schmidt et al., 2020). The public health concern associated 
with the use of medically important antimicrobials in cattle diets has caused an interest in 
discovering alternatives to replace tylosin. Antimicrobial alternatives that have been evaluated 
include oil seeds (Mir et al., 2008), vaccines (Saginala et al., 1997; Jones et al., 2004), egg yolk 




direct-fed microbials (Huebner et al., 2019). For example, Samii et al. (2016) demonstrated the 
use of limonene to decrease ruminal F. necrophorum concentrations, with 40 mg limonene/ kg 
body weight reducing ruminal F. necrophorum concentrations the most. Moreover, vaccine 
development has been a major area of study because F. necrophorum virulence factors have been 
identified and a few have been well-characterized. (Amachawadi and Nagaraja, 2016). For 
example, Fox et al. (2009) compared two commercially available vaccines, Fusogard® (Novartis 
Animal Health US, Inc, Greensboro, NC) and CenturionTM (Intervet/Schering-Plough Animal 
Health, DeSoto, KS), and demonstrated no differences in liver abscess incidence or severity 
compared to cattle not given a vaccine. Because commercially available vaccines have had low 
efficacy at preventing liver abscesses, they have not replaced the use of tylosin in the cattle industry 
(Checkley et al., 2005).  
CRISPR-Cas systems have been shown to exert inhibition of E. coli, S. aureus, K. pneumoniae, 
C. difficile, S. enterica and M. tuberculosis (Bikard et al., 2014; Gomaa et al., 2014; Kiga et al., 
2019; Li et al., 2019; Hao et al., 2020; Selle et al., 2020a). For example, CRISPR-Cas9 has been 
shown to reduce the prevalence of antimicrobial resistance genes in E. coli and S. aureus, as well 
as inhibit bacterial growth in vivo and in vitro (Bikard et al., 2014; Citorik et al., 2014; Kang et al., 
2017). CRISPR-Cas9 has also been shown to have the ability to remove plasmids containing 
antimicrobial resistance and virulence genes. For example, CRISPR-Cas9 has been reported to 
cleave plasmids in E. coli and K. pneumonia (Yosef et al., 2015; Hao et al., 2020). Furthermore, 
E. coli and C. difficile have been selectively inhibited with type I CRISPR-Cas systems (Gomaa 
et al., 2014; Selle et al., 2020b, a). CRISPR-Cas13a has also demonstrated inhibition of E. coli and 




The current study demonstrated a 1.3- to 3.3-log reduction in growth of E. coli with a plasmid 
containing the F. necrophorum rpsP gene. This gene encodes the 30S ribosomal subunit S16 
protein and the DNA sequence is specific to F. necrophorum subsp (Genebank accession 
#CP034842, National Center for Biotechnology Information, Bethesda, MD). Furthermore, few 
white colonies were observed on LL agar with x-gal, these colonies were presumed to have lost 
the plasmid containing the rpsP gene, which was confirmed by PCR. Some of the white colonies 
had a blue center, indicating that the whole plasmid was not lost after rpsP cleavage. However, 
DNA sequencing should be done to determine if the whole plasmid was lost. There were few white 
colonies observed on LL agar with x-gal compared to the 1.3- to 3.3-log reduction on LL agar with 
x-gal and kanamycin. This could be because the bacterial cells were either dying when the rpsP 
gene was cleaved or because the plasmid was not totally removed and the lac operon was still 
functional, while the kanR gene was not functional.  
Furthermore a 1.0- to 3.6-log reduction was seen when the fomA gene was targeted in F. 
necrophorum. The differences in reduction were due to controls with gRNAs 1 and 2 having a 0.9- 
and 1.1-log reduction, respectively, and the Cas9 control having a 2.0-log reduction compared the 
control with F. necrophorum only.  This is interesting because when tested in E. coli the controls 
were all within 0.4 logs of each other, with the Cas9 control being 0.2 logs lower than the control 
with E. coli only. One possibility for this finding is that F. necrophorum is an anaerobic bacterium, 
thus some cells could have died when made electrocompetent and electroporated (Langworth, 
1977). However, this possibility is doubtful because it occurred over multiple repetitions. Another 
possibility is that F. necrophorum has a CRISPR system, and therefore, could have produced 
gRNAs that worked with the Cas9 nuclease. This is unlikely because F. necrophorum’s 




National Center for Biotechnology Information, Bethesda, MD). Still, some common PAM 
sequences of type I CRISPR systems are CCN and CG, which could be used with the Cas9 
endonuclease if by random chance the CCN was a PAM of the F. necrophorum CRISPR-Cas 
system or if CG was a PAM and the target sequence was followed by CGG (Westra et al., 2013; 
Koskela et al., 2015; Guo et al., 2019; Musharova et al., 2019; Liu and Doudna, 2020). Even so, 
Cas9 requires a tracrRNA, while Cas3 only requires a crRNA making this possibility doubtful, 
nonetheless F. necrophorum’s CRISPR-Cas system has not been well characterized and could be 
why there is a reduction in bacterial cell counts when Cas9 in used alone (Deltcheva et al., 2011; 
Sinkunas et al., 2011; Gasiunas et al., 2014; Workman et al., 2021). Furthermore, when the Cas9 
control was tested in NEB 10-beta E. coli, which also has a CRISPR-Cas type I system, bacterial 
concentrations were not reduced, indicating that F. necrophorum’s endogenous CRISPR-Cas 
system is likely not causing the reduction.  
 Moreover, the current study was preliminary and therefore there are many future studies 
that should be done before determining CRISPR-Cas9 and other CRISPR-Cas systems as potential 
antimicrobial alternatives to tylosin. For example, the Cas9/gRNA ratio should be optimized for 
maximum efficiency as well as the electroporation settings. Furthermore, western blot should be 
performed to confirm the presence of Cas9 in the bacterial cells, while rt-PCR should be performed 
to determine the presence of gRNAs (Campbell et al., 2019; Sullivan et al., 2019). Fluorescent 
markers could also be used to determine the presence of Cas9 (Chen et al., 2019; Liu et al., 2020). 
Moreover, testing several gRNAs should be done to determine the most efficient gRNAs to disrupt 
the fomA gene.  
Fusobacterium necrophorum subsp. necrophorum has an endogenous type I system 




MD). Therefore, this system should be evaluated to determine how it works and how it could be 
used for gene editing or bacterial self-destruction. One key experiment that should be performed 
would be to identify the PAMS of the endogenous system. This could be done by using 
bioinformatics, high-throughput experimental screenings to disrupt target DNA, or a PAM screen 
achieved by NOT-gate repression (PAM-SCANR) (Horvath et al., 2008; Mojica et al., 2009; Jiang 
et al., 2013; Pattanayak et al., 2013; Karvelis et al., 2015). Using the endogenous system to disrupt 
genes would be beneficial to cattle production systems because only gRNAs and not Cas proteins 
would need to be delivered to the bacteria. 
Studies should also be conducted to evaluate CRISPR-Cas systems ability to disrupt the gene 
that is responsible for leukotoxin production, lktA. Fusobacterium necrophorum without the ability 
to produce leukotoxin will likely be unable to survive in the liver to cause abscesses. Experiments 
should determine if gene cleavage allows for the survival of F. necrophorum and, if so, whether 
gene disruption reduces or eliminates leukotoxin production.  
 A major obstacle will be delivering CRISPR-Cas complexes into F. necrophorum into the 
rumens of cattle. Two possible delivery methods are via nanoparticles and bacteriophages. 
Nanoparticles are microscopic particles with varying properties that have been used to deliver 
CRISPR-Cas systems to inhibit bacterial cells as well as for use in treating genetic disorders and 
cancer (Anu Mary Ealia and Saravanakumar, 2017; Chen et al., 2017; Lee et al., 2018). The second 
possible delivery method is the use of bacteriophages, which are bacterial viruses that insert DNA 
into a bacterial host. Bacteriophages can either be lytic or lysogenic and lysogenic bacteriophages 
have been used to insert CRISPR-Cas9 into Escherichia coli and Staphylococcus aureus in vitro 
(Snyder, 2013; Bikard et al., 2014; Citorik et al., 2014; Yosef et al., 2015). The delivery methods 




specificity unless a modality is added, while most bacteriophages are very target specific (Merril 
et al., 2003; Lino et al., 2018). Furthermore, nanoparticles are able to directly deliver the protein-
gRNA, while bacteriophages can be used to deliver the Cas genes and gRNA DNA sequence, 
which must be translated and transcribed in the bacterial cell (Citorik et al., 2014; Kang et al., 
2017; Kiga et al., 2019). Therefore, delivery methods should be evaluated with different Cas 
systems, including F. necrophorum’s endogenous system, to determine the most efficient delivery 
method for the system to cleave target genes.   
 Lastly, safety and product stability studies need to be conducted. Safety studies should 
include determination that there are no cattle or human health risks when using the CRISPR-Cas 
system paired with the chosen delivery method and that viable residues are not in the meat or the 
environment. Product stability studies should determine that the delivery and CRISPR-Cas 
complexes could tolerate production, handling, and administration to cattle.  
 Conclusions 
In conclusion, the rpsP and fomA genes were targeted with Cas9-gRNA complexes in E. 
coli and F. necrophorum to determine if CRISPR-Cas9 could possibly be used as an antimicrobial 
alternative. When the rpsP gene was targeted from a plasmid in E. coli, there was a 1.3- to 3.3-
log10 reduction in bacterial cell counts observed. Likewise, when the fomA gene was targeted in F. 
necrophorum, a 1.0- to 3.6-log10 reduction was observed. However, in F. necrophorum the Cas9 
control reduced bacterial cell counts by a 2.0-log10. This was not seen for the Cas9 control when 
tested in E. coli. This could be because F. necrophorum has an endogenous CRISPR-Cas type I 
system. More studies should be conducted to determine how this endogenous system works and to 
further demonstrate the potential use of CRISPR-Cas systems as antimicrobial alternatives to 





Table 6.1. PCR assay primers for rpsP and fomA genes. 
Primer Sequence 
rpsP forward primer 5’ -TCCCGGAAAGCTTTTAAAGTTAAGATTA- 3’ 
rpsP reverse primer 5’ -TCCGGGAAAGCTTTTTCTTTTTTGTTT- 3’ 
fomA forward primer 5’ - GCCGGATCCAAAGAAGTGATGCCTGCTCCT- 3’ 






Table 6.2. Sequences of guided RNAs (gRNA) targeting rpsP and fomA genes. 
gRNA Sequence 
rpsP gRNA 1 5’ -AAAGTTAAGATTAACTCGATT- 3’ 
rpsP gRNA 2 5’ -CAAGAACTGTAAAATCTATTC- 3’ 
fomA gRNA 1 5’ -ATTAGGTTCTTTATTAGTCAT- 3’ 
















































































































































Figure 6.1. Distribution of log10 for Fusobacterium necrophorum rpsP gene 























Escherichia coli rpsPFI - - - 7.7E+06 6.9 5.2 1979 
Escherichia coli rpsPFI + gRNA 1 - - - 3.3E+06 6.5 4.7 1977 
Escherichia coli rpsPFI + gRNA 2 - - - 1.2E+07 7.1 4.7 1976 
Escherichia coli rpsPFI + Cas9 - - - 4.9E+06 6.7 4.5 1975 
Escherichia coli rpsPFI + Cas9 + gRNA 1 4.75E+03 6.20E+05 0.77 % 1.7E+05 5.2 3.7 1973 
Escherichia coli rpsPFI + Cas9 + gRNA 2 2.40E+02 1.10E+04 2.18 % 6.7E+03 3.8 3.3 1973 
Escherichia coli rpsPFI + Cas9 + gRNA 1 & 2 1.39E+03 1.26E+05 1.10 % 6.8E+04 4.8 3.7 1973 
a Taken from LL agar with x-gal 





















































































































































































































Figure 6.3. Distribution of log10 CRISPR-Cas9 inhibition of Fusoacterium necrophorum 















Fusobacterium necrophorum subsp. necrophorum 8L1 1.9E+08 8.3 5.1 1978 
Fusobacterium necrophorum subsp. necrophorum 8L1 + gRNA 1 2.3E+07 7.4 5.0 1978 
Fusobacterium necrophorum subsp. necrophorum 8L1 + gRNA 2 1.4E+07 7.2 5.0 1977 
Fusobacterium necrophorum subsp. necrophorum 8L1 + Cas9 1.8E+06 6.3 3.7 1973 
Fusobacterium necrophorum subsp. necrophorum 8L1 + Cas9 + gRNA 1 4.7E+04 4.7 3.5 1972 
Fusobacterium necrophorum subsp. necrophorum 8L1 + Cas9 + gRNA 2 1.8E+05 5.3 3.6 1973 






Figure 6.4. Distribution of log10 CRISPR-Cas9 inhibition of Fusobacterium necrophorum subsp. necrophorum 8L1 only 































































F. necrophorum 8L1 + Cas9 +gRNA 1 
Figure 6.5. Distribution of log10 CRISPR-Cas9 inhibition of F. necrophorum subsp. necrophorum 8L1 + Cas9 and 
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Chapter 7 - Antimicrobial activity of Sorghum Phenolic Extract on 
Bovine Foodborne and Mastitis Causing Pathogens 
 Abstract 
Antimicrobial resistance in bacterial pathogens associated with bovine mastitis and human 
foodborne illnesses from contaminated food and water have an impact on animal and human 
health. Phenolic compounds have antimicrobial properties, and some specialty sorghum grains are 
high in phenolic compounds and the grain extract may have the potential as a natural antimicrobial 
alternative. The study’s objective was to determine antimicrobial effects of sorghum phenolic 
extract on bacterial pathogens that cause bovine mastitis and human foodborne illnesses. Bacterial 
pathogens tested included Escherichia coli, Salmonella Typhimurium, Campylobacter jejuni, 
Campylobacter coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Klebsiella oxytoca, 
Staphylococcus aureus, and Enterococcus faecalis. Antibacterial activities of sorghum phenolic 
extracts were determined by agar well diffusion assay. Sorghum phenolic extract was added to the 
wells in concentrations of 0, 100, 200, 500, 1,000, or 4,000 µg/mL. The control wells did not 
receive phenolic extract. Plates were incubated for 18-24 hours and the diameter of each zone of 
inhibition was measured. The results indicated that sorghum phenolic extract had inhibitory effects 
on Staphylococcus aureus, Enterococcus faecalis, Campylobacter jejuni, and Campylobacter coli. 
 Introduction 
Increased antimicrobial resistance due to agricultural use has become a major issue around 
the world (Aidara-Kane et al., 2018). An increase in resistance to medically important 




tetracyclines, and glycopeptides, led to increased scrutiny in the use of antibiotics in food animals 
with emphasis on antibiotic stewardship (FDA, 2015; Torio and Padilla, 2018; WHO, 2019).  
Zoonotic foodborne illnesses are a major public health concern and food-producing 
animals are a major reservoir for many of the foodborne pathogens. The three major foodborne 
bacterial pathogens that food animals harbor are Shiga toxin-producing Escherichia coli, 
Salmonella enterica, and Campylobacter species, particularly jejuni and coli. The Center for 
Disease Controls recognizes the threat of these pathogens to One Health, spanning both human, 
animals, and the environment (CDC, 2021). Brown et. al. reported that 21% of 176 Salmonella 
foodborne illness outbreaks in the United Stated between 2003 and 2012 were resistant to at least 
one antibiotic (Brown et al., 2017). Furthermore, Europe had 319 foodborne outbreaks linked to 
Campylobacter in 2019, which was 23 % of the total number of outbreaks caused by bacteria in 
Europe (European Food Safety Authority and European Centre for Disease Prevention and 
Control, 2021). Likewise, Campylobacter has been related to foodborne illness outbreaks in the 
United States and China (Roels et al., 1998; Yu et al., 2020). In 2017, the CDC reported 23 
Campylobacter outbreaks, 4 % of the total number of outbreaks caused by bacteria in the United 
States (CDC, 2017). Furthermore, illnesses involving E. coli O157 can lead to hemolytic uremic 
syndrome (Launders et al., 2016). In 2019, 42 Shiga toxin-producing E. coli outbreaks were 
reported in Europe, which was 3 % of the total number of outbreaks caused by bacteria in Europe 
(European Food Safety Authority and European Centre for Disease Prevention and Control, 2021). 
Likewise, the United States reported that Shiga toxin-producing E. coli caused 3 % of the total 
number of bacterial outbreaks in 2017 (CDC, 2017). Hemolytic uremic syndrome (HUS) is a 
severe illness involving the kidneys and central nervous system that can lead to acute renal failure 




Alpers et al., 2008). Furthermore, 87,923 human salmonellosis cases were reported in Europe in 
2019 (European Food Safety Authority and European Centre for Disease Prevention and Control, 
2021). Antimicrobial resistance coupled with foodborne illness outbreaks among Campylobacter, 
Escherichia coli O157, and Salmonella enterica are a growing public health threat (Chigor et al., 
2010; McCrackin et al., 2016; Brown et al., 2017).  
Furthermore, mastitis is an important production disease of dairy cattle. Mastitis is 
typically caused by various bacterial pathogens, such as Staphylococcus aureus, Pseudomonas 
aeruginosa, and Klebsiella, and causes reduced milk yield and economic losses to producers 
(DeGraves and Fetrow, 1993; Hortet and Seegers, 1998; Gröhn et al., 2004; Park et al., 2014). 
Ohnishi et al. (2011) demonstrated that mastitis cases associated with P. aeruginosa can lead to 
acute systemic infections that are moderate to severe. Additionally, P. aeruginosa is known to be 
multidrug-resistant and, therefore, difficult to treat (Lister et al., 2009; Ohnishi et al., 2011; Saleh 
et al., 2016; Tomlinson et al., 2016). Tenhagen et al. (2014) reported that 631 isolates of S. aureus 
from various cattle production areas were resistant to at least one antimicrobial. Isolates of 
Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa have also shown 
resistance to antimicrobials (Liu et al., 2013). These findings demonstrate the need to find 
antimicrobial alternatives for food animal medicine, either for treatment or for prevention of 
diseases.  
Antimicrobial alternatives are substitutions to existing antibiotics where bacterial 
resistance has emerged (Hoelzer et al., 2018). There are three major categories of antimicrobial 
alternatives: natural, synthetic, and biotechnology-based (Ghosh et al., 2019). Plant-based 
antimicrobial compounds are part of the naturally occurring antimicrobial alternative category 




derived from plants with antioxidant and antimicrobial activity (Srivastava et al., 2014; Anastasaki 
et al., 2017). The mode of actions for antimicrobial activity to combat these pathogens are believed 
to be the reduction of pH, disruption of the permeability of the bacterial membrane, or through 
manipulation of bacterial efflux pumps (Srivastava et al., 2014). 
Sorghum phenolic extract is a collection of plant-based compounds and a potent natural 
antimicrobial alternative (Kil et al., 2009; Villalobos et al., 2016). Likewise, it has been shown to 
have many health and pharmaceutical benefits (Dykes and Rooney, 2006). Genetic diversity offers 
some sorghum specialty lines with high tannin content and/ or high phenolic compounds that 
demonstrate high antioxidant activity (Herald et al., 2012). Also, the increased concentrations of 
phenolic compounds have been associated with higher antioxidant activities, anticarcinogenic 
effects, and antimicrobial activities (Dykes et al., 2005; Guajardo Flores, 2008; Kil et al., 2009). 
Kil et al. (2009) reported that a cultivar of sorghum phenolic extract had minimum inhibitory 
concentrations (MIC) for S. aureus, Bacillus subtilis, Salmonella Typhimurium, K. pneumoniae, 
and E. coli of 250, 250, 500, 500, and 250 µg/mL, respectively. Furthermore, Villalobos et al. 
(2016) demonstrated antimicrobial activity of soy flour phenolic extract against Listeria innocua, 
Listeria monocytogenes, Staphylococcus aureus, Bacillus cereus, and Enterococcus faecalis. 
Additionally, a sorghum extract with phenol present in high amount has been shown to attenuate 
replication of Legionella pneumophila in mouse macrophage cells (Gilchrist et al., 2020).  
The current study’s objective was to investigate antimicrobial activity of phenolic 
compounds extracted from sorghum bran against foodborne and mastitis-causing pathogens 
associated with cattle. We hypothesized that extracts from high phenolic sorghum grain would 




 Materials and Methods 
 Sorghum Plant Material 
The diversified sorghum association panel (SAP) was evaluated at Manhattan, KS and at 
Puerto Vallarta, Mexico in 2014 along with other photosensitive lines. All lines were tested for 
total phenolic compound concentrations and oxygen radical absorption capacity (ORAC) values. 
One photosensitive line PI570481 was chosen for the study as this line had ORAC values greater 
than 150 µM Trolex equivalent. The line PI570481 is a black-grained sorghum selected due to its 
efficacy and high phenolic content as previously published (Smolensky et al., 2018; Gilchrist et 
al., 2020). 
 Total Phenolic Compounds Extraction and Quantification 
A tangential abrasive dehulling device (Venables Machine Works, Saskatoon, Canada) was 
used to remove the bran. Twenty-five ml of acidified methanol (1 % HCl/methanol v/v) was used 
to suspend 0.5 g of the bran sample, which was then shaken for two hours. The mixture was 
centrifuged for 15 minutes, and the supernatant was transferred into 50 ml tubes. Total phenols in 
the sorghum bran extract were determined using the method described by Herald et al. (2012). 
Seventy- five μl of water was added to each well in a 96-well plate. Twenty-five µl of sample 
extract, Trolox standard (6-Hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid), or blank, 
along with 25 µl Folin-Ciocalteu reagent, were then added to each well and allowed to equilibrate 
at room temperature for 6 minutes. After equilibrating, 100 µl of 7.5 % Na2CO3 was added to each 
well. The plate was placed at room temperature and left in the dark for 90 minutes. The absorbance 
was measured with a Synergy 2 microplate reader (BioTek, Winooski, VT) at 765 nm and reported 
as mg gallic acid equivalents (GAE)/g of sorghum bran. Four replicates were used to measure each 




 Antimicrobial Susceptibility Testing of Sorghum Phenolic Extract 
 Preparation of bacterial inocula 
Staphylococcus aureus VDL3-SA-2017, Pseudomonas aeruginosa VDL4-PA-2017, 
Klebsiella pneumoniae VDL1-KP-2017, and Klebsiella oxytoca VDL2-KO-2017 isolated from 
bovine milk samples at the Kansas State Veterinary Diagnostic Laboratory, Escherichia coli 
O157:H7 (2017-5-590), Escherichia coli O157:H7 (2017-5-493), and Escherichia coli O157:H7 
(380-94) isolated from bovine feces, and Enterococcus faecalis ATCC 29212 were streaked onto 
blood agar plates (Remel Inc., Lenexa, KS) and incubated at 37 °C for 24 hours. Campylobacter 
jejuni and Campylobacter coli were streaked onto Mueller-Hinton (MH) agar (Becton Dickinson, 
Sparks, MD) and incubated at 37 °C for 24 hours in a tri-gas incubator under a microaerophilic 
condition. A single colony of each species from the plates was then suspended into 10 ml of 
phosphate buffer saline (PBS; Becton Dickinson, Sparks, MD) until a turbidity equivalent to 0.5 
McFarland standard was achieved per CLSI guidelines (CLSI, 2018).  
 Agar well diffusion assay 
The antimicrobial activities of the sorghum phenolic extract were determined by a well 
diffusion assay (Rammelsberg and Radler, 1990). Sixteen mm diameter wells were punched into 
MH agar (Becton Dickinson and a small amount (approx. 30 µL) of melted MH agar was used to 
seal the bottom of the wells. A cotton swab was used to inoculate bacterial inoculum of the 
bacterial species to be tested onto MH agar with wells to obtain a lawn of growth. The wells were 
then filled with 100 µL of sorghum phenolic extract at concentrations of 0 (control), 100, 200, 500, 
1,000, or 4,000 µg/ml with LB broth. Seventy percent ethanol was used to dissolve the sorghum 




for 24 hours aerobically or under microaerophilic conditions (for Campylobacter spp.). The 
diameter of the inhibitory zone was recorded.  
 Antibiotic Susceptibility Determinations 
Minimum inhibitory concentrations of antibiotics were determined by micro-broth dilution 
method [48]. Antibiotics tested were erythromycin and tetracycline (Sigma-Aldrich, St. Louis, 
MO). Antibiotic stock solutions were prepared as per manufacturer’s guidelines to obtain a 
concentration of 1,000 µg/ml based on potency of antibiotics. Antibiotics were tested at 
concentrations of 100, 50, 25, 12.5, 6.25, 3.125, 1.56, 0.78, 0.39, 0.195 and 0.098 µg/ml. The 
bacterial inocula were prepared by preparing 1:100 dilutions of cultures grown in 10 ml Mueller 
Hinton broth for 6 to 8 h. The antimicrobial susceptibility was performed in 96-well micro titer 
plates (Becton and Dickinson, Franklin Lakes, NJ). Plates were incubated at 37 °C for 20-24 h 
under aerobic (Enterococcus faecalis and Staphylococcus aureus) and or microaerophilic 
conditions (Campylobacter coli and C. jejuni) and results were recorded as growth or no growth. 
The procedure was repeated again with different bacterial inoculum. As a reference standard, 
sorghum phenolic compound was also subjected for testing at the same concentration like 
antibiotics.  
 Statistical Analysis 
The inhibitory activity of sorghum phenolic extract against foodborne illness and mastitis 
causing bacterial pathogens was evaluated using a PROC MIXED procedure in SAS (Version 9.4, 
Cary, NC). The statistical model included the concentrations of phenolic extract, replications 
(repeated measures as a random effect) and zone diameter of well diffusion assay. For the MIC 




bacterial isolates against various concentration of phenolic extract were tested using Tukey’s 
Honest Significant Difference with an alpha of ≤ 0.05.   
 Results 
 Food borne pathogens 
The sorghum phenolic extract did not inhibit E. coli O157:H7 and S. Typhimurium but 
inhibited C. jejuni and C. coli (P ≤ 0.0001; Table 7.1). The average zones of inhibition 
demonstrated for C. jejuni at concentrations of 0 µg/ml (control), 100 µg/ml, 200 µg/ml, 500 
µg/ml, 1,000 µg/ml, and 4,000 µg/ml were 0.7, 1.9, 4.6, 6.8, and 13.2 mm, respectively. The zone 
of inhibition with different concentrations did differ significantly (P ≤ 0.0001; Tables 7.1 and 7.2). 
The average zones of inhibition against C. coli at concentrations of 0 µg/ml (control), 100 µg/ml, 
200 µg/ml, 500 µg/ml, 1,000 µg/ml, and 4,000 µg/ml were 0.0, 1.2, 2.4, 4.1, 6.8, and 13.0 mm, 
respectively. The concentration effect on zone of inhibition was significant (P < 0.05; Tables 7.1 
and 7.2). 
 Mastitic pathogens 
Overall, sorghum phenolic extract did not have inhibitory effects on P. aeruginosa, K. 
pneumoniae, and K. oxytoca (Table 7.1). However, significant inhibitory effects were observed 
between different concentrations of sorghum phenolic extract against P. aeruginosa, K. 
pneumoniae, and K. oxytoca (Tables 7.1 and 7.2). There were statistical differences seen for the 
following comparisons of within and between sorghum phenolic extract concentrations when 
tested against P. aeruginosa and K. pneumoniae (P < 0.0001). The concentrations of sorghum 
phenolic extract with the largest zones of inhibition when used against K. pneumoniae were 100 
µg/ml and 200 µg/ml, both with zones of inhibition of 1.3 mm. The zones of inhibition from 




following concentration comparisons: 0 µg/ml (control) vs. 1,000 µg/ml, 100 µg/ml vs. 4,000 
µg/ml, 200 µg/ml vs. 4,000 µg/ml, and 500 µg/ml vs. 4,000 (P = 0.05). The concentration that 
sorghum phenolic extract had the greatest zone of inhibition for K. oxytoca was 4,000 µg/ml with 
a zone of inhibition of 2.4 mm.  
The overall inhibitory effect of sorghum phenolic extract was significant when tested 
against Staphylococcus aureus (P ≤ 0.0001; Table 7.1). The average zones of inhibition recorded 
for S. aureus at various concentrations of 0 µg/ml (control), 100 µg/ml, 200 µg/ml, 500 µg/ml, 
1,000 µg/ml, and 4,000 µg/ml were 0.0, 2.8, 3.4, 4.1, 5.2, and 7.7 mm, respectively, which was 
significant when tested between concentrations (P < 0.05). When compared between sorghum 
phenolic extract concentrations all comparisons had P-values less than 0.05 (Tables 7.2 and 7.3).  
 Opportunistic commensal bacteria 
The overall inhibitory effect of sorghum phenolic extract was significant when tested 
against Enterococcus faecalis (P ≤ 0.0001; Table 7.1). The average zones of inhibition 
demonstrated when sorghum phenolic extract was tested against E. faecalis at concentrations of 0 
µg/ml (control), 100 µg/ml, 200 µg/ml, 500 µg/ml, 1,000 µg/ml, and 4,000 µg/ml were 0.0, 1.7, 
2.3, 3.0, 4.3, and 8.2 mm, respectively. The zone of inhibition in comparison with the various 
tested concentrations did differ significantly (P ≤ 0.05; Tables 7.2 and 7.3). 
 Minimum inhibitory concentrations of antibiotics and sorghum phenolic 
compounds 
MIC testing was performed for the two most commonly used antibiotics in cattle 
production systems for prophylaxis and therapeutic purposes. Antimicrobial susceptibility testing 
was done for 4 bacterial isolates (Enterococcus faecalis, Staphylococcus aureus, Campylobacter 




Campylobacter coli and C. jejuni isolates were susceptible to erythromycin and tetracycline 
antibiotics. The C. coli isolate had an MIC value of 6.25 µg/ml and 1.56 µg/ml for erythromycin 
and tetracycline, respectively. The C. jejuni isolate had an MIC value of 3.12 µg/ml and 1.56 µg/ml 
for erythromycin and tetracycline, respectively. Both, E. faecalis and S. aureus isolates were 
resistant to erythromycin and tetracycline antibiotics (>100 µg/ml).  Consistent with the well 
diffusion assay, the sorghum phenolic compound was found inhibitory against all four bacteria by 
the microbroth dilution procedure with an MIC value of 12.5 µg/ml, 12.5 µg/ml, 12.5 µg/ml, and 
6.25 µg/ml for Campylobacter coli, C. jejuni, E. faecalis and S. aureus isolates, respectively.  
 Discussion 
Antimicrobial alternatives to control foodborne illness and bovine mastitis causing 
pathogens are crucial for researchers to explore. Foodborne illness outbreaks caused by 
Escherichia coli O157, Salmonella Typhimurium, and Campylobacter cause economic impacts on 
communities due to decreased worker production and in some cases, they can cause serious disease 
capable of resulting in death (Launders et al., 2016; Vygen-Bonnet et al., 2017; Salaheen et al., 
2019; Smith et al., 2019). Furthermore, mastitis causes economic losses to milk producers and is 
a major health concern for lactating cows (Halasa et al., 2007; Ohnishi et al., 2011). Our findings 
suggest that sorghum phenolic extract has antimicrobial effects against Campylobacter, but not E. 
coli O157 or S. Typhimurium. We also observed antimicrobial effects against Staphylococcus 
aureus, a Gram-positive mastitis causing bacterium, and Enterococcus faecalis, a Gram-positive 
bacterium, a major nosocomial pathogen, particularly in severely immunocompromised 
individuals. Sorghum phenolic extract had no observed antimicrobial effect on Gram-negative 
bacteria studied, except for Campylobacter, while it had antimicrobial effects on both Gram-




it was inhibited by the sorghum phenolic extract. Other high antioxidant compounds have been 
demonstrated to inhibit Campylobacter as well (Xiaonan et al., 2011; Duarte et al., 2015). For 
example, Duarte et. al. (2015) reported coriander essential oil and linalool to have zones of 
inhibition that were about 85 mm. The rest of the Gram-negative bacteria tested showed no 
inhibition and this could be due to their lipopolysaccharide outer member protecting them from 
penetration of sorghum phenolic extract (Villalobos et al., 2016). A limitation to this study was 
that the screening of sorghum was not exhaustive and instead represents a screening of sorghums 
with known high phenolics. Questions of which specific compound(s) in sorghum has efficacy, 
and the representation of those compound(s) in the diversity of sorghum was not in the scope of 
this project. Furthermore, a second limitation was that only two species of Gram-positive bacteria 
were tested, but the findings are similar to other researchers (Villalobos et al., 2016; Akogou et 
al., 2018). Akogou et. al. (2018) demonstrated no antimicrobial activity of red, phytoalexin- rich 
sorghum extract against E. coli O157. Likewise, Villalobos et al. (2016) demonstrated that Gram-
positive bacteria were more likely to be inhibited by natural phenolic extract from soybeans. 
However, the previous authors did show inhibitory effects on E. coli and Salmonella at 1,250 and 
1,500 µg/mL (Villalobos et al., 2016). Furthermore, Kil et al. (2009) demonstrated sorghum 
phenolic extract to have minimum inhibitory concentrations of less than 1,000 µg/ mL for S. 
aureus, Salmonella Typhimurium, Klebsiella pneumonia, and Escherichia coli for four different 
sorghum lines. These results are different than our findings but could be due to different methods 
used to determine antimicrobial activity or, more likely, differences in the sorghum cultivars used. 
Furthermore, an upward dose dependent trend of antimicrobial activity was seen for C. jejuni, C. 
coli, E. faecalis, and S. aureus with 100 ug/ mL having the lowest zone of inhibition and 4,000 




Apart from Campylobacter, Gram-negative foodborne illness causing bacteria used in this 
study were not inhibited by sorghum phenolic extract. However, sorghum grain from different 
sorghum cultivars could still be used as an antimicrobial alternative to these bacteria. For example, 
Kumar et al. (2012) engineered silver glyconanoparticles using sweet sorghum syrup that were 
shown to have antimicrobial effects on E. coli, P. aeruginosa, and Klebsiella planticola, as well 
as some Gram-positive bacteria. Furthermore, Halder et al. (2019) identified a glycine and proline 
rich protein in sorghum that has demonstrated antimicrobial activity against Bacillus subtilis, 
Rhodococcus fascians, and Escherichia coli with minimum inhibitory concentrations of 7.5, 22.4, 
and 75 µg/mL, respectively. Together these findings demonstrate how sorghum grain can be used 
in different ways to develop antimicrobial alternatives and how further research should be 
conducted on sorghum antimicrobial effects. 
 Conclusions 
Our data demonstrated that phenolic extract of a sorghum cultivar exhibited antibacterial 
activity.  Of the mastitis-causing pathogens and foodborne pathogens prevalent in cattle tested, 
only S. aureus, E.  faecalis, C.  jejuni, and C. coli were inhibited by the phenolic extracts in a dose 
dependent manner.  The selective inhibition of certain bacterial species, both Gram-positive and 
Gram-negative bacteria, and not against other bacterial species is an interesting observation that 
needs to be investigated.  Our study provides impetus to test additional cultivars of phenolic acid 
extracts of sorghum cultivars and explore value-added benefits of sorghum grains as natural 





Table 7.1. Overall antimicrobial effects of sorghum phenolic extract. 
 Sorghum phenolic extract concentration 
(µg/mL) 
P-value 
 0 100 200 500 1000 4000 
Bacterial species and strain 
number 
ZOIa ZOIa ZOIa ZOIa ZOIa ZOIa 
Escherichia coli O157 2017-5-590 0 0 0 0 0 0 - 
Escherichia coli O157 2017-5-493 0 0 0 0 0 0 - 
Escherichia coli O157 380-94 0 0 0 0 0 0 - 
Campylobacter jejuni 2016-12-
17A 
0 0 0 4.1 5.8 11.1 0.0002 
Campylobacter coli 2016-12-82A 0 1.4 3.2 3.8 7.0 12.7 0.0016 
Campylobacter coli 2016-12-80A 0 0 0.8 3.8 5.8 11.7 <0.0001 
Campylobacter coli 2016-12-181A 0 2.3 3.3 4.8 7.7 14.7 0.0004 
Salmonella Typhimurium ATCC 
14028 
0 0 0 0 0 0 - 
Staphylococcus aureus VDL3-
SA-2017 
0 2.8 3.4 4.1 5.2 7.7 0.0001 
Pseudomonas aeruginosa VDL4-
PA-2017  
0 0 0 0 0 0.3 - 
Klebsiella pneumoniae VDL1-
KP-2017 
0 1.3 1.3 0.9 0 0.8 0.8887 
Klebsiella oxytoca VDL2-KO-
2017 
0 0 0 0 0.8 2.4 - 
Enterococcus faecalis ATCC 
29212 
0 1.7 2.3 3.0 4.3 8.2 0.0003 











 Sorghum Phenolic Extract 
Concentration (µg/mL) 
Mean differences with the P-values 
 100 200 500 1000 4000 100 v. 200 100 v. 500 100 v. 1000 100 v. 4000 200 v. 500 200 v. 1000 200 v. 4000 500 v. 1000 500 v. 4000 1000 v. 4000 
Bacteria ZOIa ZOIa ZOIa ZOIa ZOIa SEM P SEM P SEM P SEM P SEM P SEM P SEM P SEM P SEM P SEM P 
E. coli O157 
2017-5-590 
0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - 
E. coli O157 
2017-5-493 
0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - 
E. coli O157 
380-94 
0 0 0 0 0 - - - - - - - - - - - - - - - - - - - - 
C. jejuni 2016-
12-17A 
0 0 4.1 5.8 11.1 
1.55E
-15 
1.00 -4.08 <.0001 -5.75 <.0001 
-
11.08 
<.0001 -4.08 <.0001 -5.75 <.0001 
-
11.08 
<.0001 -1.67 <.0001 -7.00 <.0001 -5.33 <.0001 
C. coli 2016-
12-82Ac 
1.4 3.2 3.8 7.0 12.7 -1.75 0.0001 -2.33 <.0001 -5.58 <.0001 
-
11.25 
<.0001 -0.58 0.1226 -3.83 <.0001 -9.50 <.0001 -3.25 <.0001 -8.92 <.0001 -5.67 <.0001 
C. coli 2016-
12-80Ac 
0 0.8 3.8 5.8 11.7 -0.75 0.0255 -3.75 <.0001 -5.75 <.0001 
-
11.67 
<.0001 -3.00 <.0001 -5.00 <.0001 
-
10.92 
<.0001 -2.00 <.0001 -7.92 <.0001 -5.92 <.0001 
C. coli 2016-
12-181A 
2.3 3.3 4.8 7.7 14.7 
-
1.083 
0.1650 -2.50 0.0036 -5.42 <.0001 
-
12.42 
<.0001 -1.42 0.0746 -4.33 <.0001 
-
11.33 

























































1.00 -0.33 <.0001 
5.55E
-17 




1.3 1.3 0.9 0 0.8 
-
0.083 











1.00 -0.83 0.4575 -2.38 0.0441 
8.88E
-16 
1.00 -0.83 0.4575 -2.38 0.0441 -0.83 0.4575 -2.38 0.0441 -1.54 0.1771 
E. faecalis 
ATCC 29212 
1.7 2.3 3.0 3.4 6.5 -0.67 0.5496 -1.29 0.2527 -1.75 0.1268 -4.83 0.0003 -0.63 0.5746 -1.08 0.3348 -4.17 0.0013 -0.46 0.6800 -3.54 0.0045 -3.08 0.0113 
a ZOI: average zone of inhibition (diameter; mm) 




Table 7.3. Comparison of antimicrobial effects of different concentrations of sorghum phenolic extract vs. control. 
 
 
 Sorghum Phenolic Extract Concentration (µg/mL) Mean differences with the P-values 
 0 100 200 500 1000 4000 0 v. 100 0 v. 200 0 v. 500 0 v. 1000 0 v. 4000 
Bacteria ZOIa ZOIa ZOIa ZOIa ZOIa ZOIa SEM P SEM P SEM P SEM P SEM P 
E. coli O157 2017-5-
590 
0 0 0 0 0 0 - - - - - - - - - - 
E. coli O157 2017-5-
493 
0 0 0 0 0 0 - - - - - - - - - - 
E. coli O157 380-94 0 0 0 0 0 0 - - - - - - - - - - 
C. jejuni 2016-12-
17A 
0efg 0 0 4.1e 5.8f 11.1g 0 1.0000 6.66E-16 1.0000 -4.08 <.0001 -5.75 <.0001 -11.08 <.0001 
C. coli 2016-12-82A 0h 1.4c 3.2d 3.8e 7.0f 12.7g -1.42 0.0010 -3.17 <.0001 -3.75 <.0001 -7.00 <.0001 -12.67 <.0001 
C. coli 2016-12-80A 0defg 0 0.8d 3.8e 5.8f 11.7g 
-178E-
17 
1.0000 -0.75 0.0255 -3.75 <.0001 -5.75 <.0001 -11.67 <.0001 
C. coli 2016-12-
181A 
0h 2.3c 3.3d 4.8e 7.7f 14.7g -2.25 0.0076 -3.33 0.0003 -4.75 <.0001 -7.67 <.0001 -14.67 <.0001 
S. Typhimurium 
ATCC 14028 
0.5 0 0 0 0 0 1.73 0.1004 1.73 0.1004 1.73 0.1004 1.73 0.1004 1.73 0.1004 
S. aureus VDL3-SA-
2017 
0h 2.8c 3.4d 4.1e 5.2f 7.7g -0.63 0.0007 -1.29 <.0001 -2.38 <.0001 -4.88 <.0001 -0.67 0.0004 
P. aeruginosa VDL4-
PA-2017  
0h 0c 0d 0e 0f 0.3g 1.083 <.0001 1.083 <.0001 1.083 <.0001 1.083 <.0001 0.75 <.0001 
K. pneumoniae 
VDL1-KP-2017 
0f 1.3 1.3 0.9 0f 0.8 -0.1667 0.3101 -0.25 0.1346 0.17 0.3101 1.083 <.0001 0.25 0.1346 
K. oxytoca VDL2-
KO-2017 
0g 0 0 0 0.8 2.4g 
1.78E-
15 
1.0000 1.33E-15 1.000 2.22E-15 1.0000 -0.83 0.4575 -2.38 0.0441 
E. faecalis ATCC 
29212 
0defg 1.7 2.3d 3.0e 3.4f 6.5g -1.52 0.1447 -2.13 0.0468 -2.71 0.0145 -3.13 0.0058 -5.95 <.0001 
a ZOI: average zone of inhibition (diameter; mm) 
b SEM: standard error of the mean 
c evidence of statistical difference between 0 v. 100 µg/mL at α = 0.05 
d evidence of statistical difference between 0 v. 200 µg/mL at α = 0.05 
e evidence of statistical difference between 0 v. 500 µg/mL at α = 0.05 
f evidence of statistical difference between 0 v. 1000 µg/mL at α = 0.05 
g evidence of statistical difference between 0 v. 4000 µg/mL at α = 0.05 








Figure 7.1. Antibacterial effects of sorghum phenolic extract concentrations for Campylobacter jejuni, 
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